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ABBREVIATIONS AND SYMBOLS 
aa   amino acid 
Ap   ampicillin 
APS   ammonium persulfate 
ATP   adenosine triphosphate 
bp   base pair 
BSA   bovine serum albumin 
CDI   Clostridium difficile infection 
Cm   chloramphenicol 
dH2O   distilled water 
DNA   deoxyribonucleic acid 
DNase   deoxyribonuclease 
dNTP   deoxynucleosyl triphosphate  
EDTA   ethylenediaminetetraacetic acid 
EPS   extracellular polysaccharide 
Gm   gentamycin 
His   histidine 
IMAC   immobilised metal chelating chromatography 
kb   kilobase pair 
kDa   kilodalton 
Kn   kanamycin 
LB   lysogeny broth 
LPS   lipopolysaccharide 
MRSA   meticilin resistant Staphylococcus aureus 
MurA    UDP-N-acetylglucosamine enolpyruvyl transferase 
MurB    UDP-N-acetylpyruvyl glucosamine reductase 
MurC    UDP-N-acetylmuramoyl:L-alanine ligase 
MurD    UDP-N-acetylmuramoyl:L-alanine:D-glutamate ligase 
MurE  UDP-N-acetylmuramoyl:L-alanine:D-glutamate:meso 
diaminopimelate ligase 
MurF  UDP-N-acetylmuramoyl:L-alanine:D-glutamate-meso-
diaminopimelate:D-alanyl-D-alanyl ligase  
NaCl   sodium chloride 
NaOH   sodium hydroxide 
nt   nucleotide 
OD650   optical density at 650 nanometres 
PEP   phosphoenolpyruvate 
PG   peptidoglycan 
PCR   polymerase chain reaction 
RNA   ribonucleic acid 
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RNase   ribonuclease 
rpm   revolutions per minute or rotations per minute 
RT   room temperature 
SDS   sodium dodecyl sulphate 
SDS-PAGE  sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Sm   streptomycin 
spp.   species pl. 
TBE   tris/borate/EDTA 
TBS   tris buffered saline 
Tc   tetracycline 
TEMED  tetramethyl ethylenediamine 
Tris   Tris [hydroxyethyl] aminomethane  
tRNA   transfer ribonucleic acid  
U   enzyme unit 
UV   ultraviolet 
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1 INTRODUCTION 
The discovery of antibiotics has greatly changed the treatment of bacterial infections. 
Serious and fatal infections have become treatable. However, due to the inappropriate 
use of antibiotics, the resistance of bacteria has rapidly increased. Antimicrobial 
therapies induced a selective pressure on bacteria to survive only the ones with 
favorable genetic changes. These changes can rapidly spread due to rapid reproduction 
and mechanisms that allow the transfer of genetic material (Walsh, 2000).  
Clostridium difficile is one of the bacteria’s thought out as one of the most important 
sources of health care-releated infections (Oren and Rupnik, 2018). Recently it was 
proposed to use Clostridioides difficile instead of C. difficile. The decision was made 
based on the improved genetic, phenotypic testing and protein sequencing. C. difficile 
infections are appearing in the community patients and in animals utilized for food 
and are becoming more than just simple troublesome obstacle that results after 
antibiotic therapy. In the last years, occurrence and intensity of C. difficile infection 
(CDI) has increased remarkably, leading to expanded research attentiveness and the 
uncovering of unknown virulence factors. CDI take place immediately after the gut 
microbiota is reduced by antibiotic treatmant (Rupnik et al., 2009). Antibiotics result 
in different patterns of alternation to the microbiome composition, depending on 
which class of antibiotics is used, dose and the period of exposure (Iizumi et al., 
2017). Antibiotics fidaxomicin, metronidazole and vancomycin are used for the 
treatment of CDI. However, despite the available treatment some C. difficile strains 
are resistant to a broad scope of antibiotics which makes it possible to colonize and 
infect despite the use of antibiotics (Peng et al., 2017). 
The focus expended on the development of new treatment mainly because of the 
rapidly increasing resistance to antimicrobial agents. This has increased the need to 
establihs novel strategies for the treatment of bacterial infections, and thus the search 
for new antimicrobials acting on new targets. In identifying new potential targets, 
researchers focus primarily on the differences between human and bacterial cells, as 
antibacterial agents have to be selectively toxic. The main difference between the 
cells is bacterial cell wall, which is missing in human cells. An important compound 
of bacterial cell wall is peptidoglycan, which is present in Gram-positive and Gram-
negative bacteria. The extracellular steps of peptidoglycan biosynthesis as targets 
have been long known and used for the development of β- lactam and glycopeptide 
antibiotics, and now the attention is shifting to an intracellular steps of peptidoglycan 
biosynthesis (Gautam et al., 2011b). Intracellular step is catalyzed by family of Mur 
ligases (MurA to MurF), which are specific for bacteria and therefore present the new 
most potential targets for development of new antimicrobial agents (El Zoeiby et al., 
2003). Mur enzymes are promising targets for the discovery of new inhibitors with 
antibacterial activity. Inhibitors that binds to more than one Mur ligases recognizes 
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homologous binding motifs Mur ligase enzyme in the pathway having UDP-sugar as 
a substrate and could be used as multitarget drug to increase the therapeutic 
effectiveness. 
1.1 AIM AND SCOPE 
The aim of this Master thesis was production of recombinant Mur enzymes and 
detection and screening of potential antimicrobial inhibitors obtained as extracts from 
Actinobacteria for Mur ligases (MurA and MurB) in Clostridium difficile. For this 
purpose, the native genes of Mur ligases from C. difficile were first subcloned into 
Escherichia coli and over-produced in E. coli BL21 and in insect cells. The 
corresponding recombinant proteins was purified as His6-tagged forms. The aim was 
also to obtain active purified recombinant protein, which was measured based on the 
inorganic phosphate generated from the Mur ligase reaction. Moreover, for comparison 
to native Mur ligases also synthetic genes were ordered and screened for potential 
antimicrobial inhibitors and activity. Biochemical properties of Mur ligases were 
analyzed with SDS-page and were compared to the synthetic proteins from C. difficile.  
1.1.1 Hypotheses  
H0: successful cloning of MurA and MurB ligases from Clostridium difficile  
H1: overproduction of active recombinant MuA and MurB proteins  
H2: with the established screening method, we can determine the antimicrobial potential 
of actinobacterial inhibitors of MurA and MurB ligases in Clostridium difficile 
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2 LITERATURE REVIEW  
2.1 Clostridium difficile  
Clostridium difficile is a Gram-positive bacterium which lives in an anaerobic 
environment. Is a cytotoxin producing bacillus (Kelly and Lamont, 2008). C. difficile is 
a spore forming bacteria and due to its absolute anaerobic necessity, the dormant spore 
is the infectious and spreading morphotype (Paredes-Sabja et al., 2014).  
Clostridium difficile was first considered to be non-pathogenic until they identified the 
cytotoxin to be produced by it (Lessa et al., 2012). Since then the awareness of the 
pathogenesis, diagnosis, epidemiology and clinical administration of C. difficile 
infection (CDI) has extended extremely.  
CDI has become a major world wide challenge associated to public health. Production 
of toxin in high levels and resistance to fluoroquinolones have contributed to make a 
virulent strain a very strong pathogen in healthcare facilities. Analysis of C. difficile 
genome show multiple mechanisms of modifications and functionality, which can make 
the bacteria to adjust easily to environmental changes, even leading to enhanced virulent 
strains (Lessa et al., 2012).  
2.1.1 Pathogenesis of Clostridium difficile 
Clostridium difficile is often spread in health care facilities, usually on the grounds of 
transsmisible spores from other patients via the hands of the healthcare  ingestion of 
spores transferred from other patients through the hands of healthcare employees or the 
surroundings (Shaughnessy et al., 2011). The spores are highly resistant to 
environmental conditions, including the acid produced in the stomach. Spores germinate 
into the vegetative cells in the small intestine, they are also capable of adhering to colon 
cells (Lessa et al., 2012). Disturbance of normal gut microbiota, usually by introduction 
to antibiotics, makes the proliferation of C. difficile feasible (Kuijper et al., 2006).  
Clostridium difficile infection can result in variety of diseases: toxic megacolon, 
pseudomembranous colitis (PMC), perforations of the colon, sepsis and in rare occasios 
can lead to death. Symptoms that occur while infected by C. difficile are diarrhea, 
abdominal pain, loss of appetite, fever and nausea. Diarrhea caused by C. difficile can 
occur again in 5-30 % of treated people, mainly because of the infection with the new 
strains of C. difficile (Rupnik et al., 2009).  
Pathogenic strains of C. difficile produce two large exotoxins, toxin A and toxin B 
encoded in the C. difficile pathogenicity locus (plaoc), by their genes, TcdA and TcdB. 
The genes are located, along with two additional regulatory genes TcdC (encodes a 
toxin gene repressor) and TcdD (toxin transcription regulator) (Navaneethan et al., 
2010). The fifth gene on pathogenicity locus is tcdE, which is responsible for the cell 
wall lysis  and the release of toxin A and B into the colonic lumen (Poxton et al., 2001). 
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The two toxins contain a 49 % amino acid homology and own a N-terminal domain 
which carry cytotoxic activity, a transmembrane domain that enables toxin entry into 
the cytoplasm and a C-terminal domain that advocates the binding of toxin to the 
epithelial cells (Sun et al., 2010). Both toxins are UDP-glucose hydrolases and 
glucosyltransferases contributing to contagious and inflammatory diarrhea (Riegler et 
al., 1995). In the first step both toxins contribute to the binding of the bacteria to the 
colonic epithelial cells. The second step is toxin entrance in the cell by endocytosis 
through receptors and the catalytic reaction of the transfer of glucose residue to 
guanosine triphosphate Rho proteins from UDP-glucose. Rho proteins are signaling 
molecules which regulate gene expression and organizes cytoskelet  (Navaneethan et 
al., 2010). They work as molecular switches and are involved in different signal 
processes and are the main substrates of TcdA and TcdB. Glycosylation of Rho proteins 
(Ras superfamily) in results in interruption of protein synthesis, and cell death. As the 
consequence  inflammatory diarrhea occurs in patients with CDI (Cowardin et al., 2016) 
Toxin-negative C. difficile strains are non-pathogenic. Individual strains of C. difficile 
can produce the third toxin recognized as transferase toxin (CDT) which is located 
outside the paloc, and is encoded by ctdA and ctdB. The part of binary toxin in the 
pathogenesis of C. difficile is depolymerisation of actin, thereby inducing formation of 
the microtubule-based protrusions (Cowardin et al., 2016). The presence of the third 
toxin among th epidemic strains BI/NAP1/027 has lifted concearns about its synergy 
with toxins A and B in inducing severe colitis (Kelly and Lamont, 2008). For the 
development of CDI both exposure to antimicrobial and toxin producing strains of C. 
difficile is necessary. The role of host factors have an important role in the development 
of CDI due to some patients even with the exposure to both causes do not show 
symptoms of CDI (Gould and McDonald, 2008).  
 
Figure 1: C. difficile toxins A (TcdA) and B (TcdB) (Aktories et al., 2017) 
Toxin A and B contain four domains. Domain A is glucosyltransferase. Domain B is involved in binding. 
Domain C is an autoprotease domain and is connected to domain D. Domain D assists delivery and 
binding to host cells. 
Slika 1: Struktura toksina A (TcdA) in B (TcdB) C. difficile (Aktories in sod., 2017) 
Oba toksina sestavljajo štiri domene. Domena A je glukoziltransferaza. Domena B je za vezavo toksina. 
Domena C je avtoproteazna domena in je povezana z domeno D. Domena D je vključena v dostavo in 
tudi v vezavo na gostiteljske celice.  
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2.1.2 Antibiotic resistance of Clostridium difficile  
Resistance to antibiotics is a term that refers to continues growth of microorganisms in 
the presence of cytotoxic concentrations of antibacterial agents (Zaman et al., 2017). 
We distinguish two type of resistance intrinsic and acquired (Lemke and Williams, 
2012). Intrinsic resistance is the result of mutations in the bacterial genome, which are 
naturally present on the bacterial chromosome. The mentioned resistance occurs less 
frequently due to the presence of mechanisms that repair damaged DNA. The acquired 
resistance is more frequent and is the result of vertical gene transfer in the division of 
the bacterium or the vertical transfer of genetic material between the various bacterial 
strains (Tenover, 2006).  
Antibiotic treatment is crucial to the induction and resolution of C. difficile infections 
(Lewis et al., 2015). C. difficile is a sporogenic bacterium which limits the functioning 
of various antimicrobial compounds, which target mainly metabolically active cells and 
are limited or non-proactive against dormant cells such as spores. The resistance of 
spores facilitates C. difficile to remain alive in the presence of antibiotics or in the host 
immune system. Vegetative cells of C. difficile are sensitive to teicoplanin and 
vancomycin regardless of having a genomic region that resembles a vanG glycopeptide 
resistance cluster. This region may give resistance to vancomycin to a heterologous 
host, but it is unclear why it is not functional in C. difficile. The mobile genome of C. 
difficile contains different resistance determinant that can confer resistance to antibiotics 
such as linezolid and tetracycline (Smits et al., 2016). Furthermore, other types of 
mechanisms of resistance have been discovered in C. difficile, which includes transfer 
of genetic elements and changing the target site of the antibiotic (Spigaglia, 2016). One 
of the important mechanisms of resistance to antibiotics is biofilm. Its formation is 
initiated by intrinsic mechanisms and by the introduction to antibiotics (Lin et al., 
2015). Research in recent years show reduced susceptibility or resistance to the 
commonly used antibiotics (Smits et al., 2016). C. difficile clinical isolates are resistant 
to metronidazole (Chong et al., 2014). It has been also noted that some C. difficile 
mutants show lower susceptibility to fidaxomicin or vancomycin (Leeds et al., 2014).  
Metrodinazole is one of the first antibiotics used for treatment of mild to moderate C. 
difficile infections. Some C. difficile strains have shown reduced susceptibility to 
metrodinaloze whih can be problematic. Genes encoding resistance to metrodinazole 
have not been identified yet, therefore the mechanisms of resistance is not fully 
understood. Studies suggests that mechanism of resistance to metrodinazole includes 
many factors such as changes in different metabolic pathways (Spigaglia, 2016). Most 
recent research in Iran show the appearance of metronidazole and vancomycin 
resistance in Clostridium difficile isolates (Kouhsari et al., 2019). The study investigated 
the toxigenic C. difficile isolates from diarrhea stool samples of patients with CDI and 
evaluated their antimicrobial resistance. 
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2.2 ANTIMICROBIAL AGENTS 
Active substances used to fight bacteria can be divided in two groups – to antibiotics 
and synthetic antimicrobial agents. Antibiotics were originally defined as natural 
products of different microorganisms, and nowadays they constitute any agent used for 
treatment of infections utilizing the bactericidal or bacteriostatic activity. To achieve 
higher antimicrobial spectrum, greater potency, lower toxicity or to improve others 
pharmacokinetic properties their semi-synthetic analogues are used. Synthetic 
substances which are not products of microorganism but are used to kill or inhibit 
bacterial growth are ranked as synthetic antimicrobial agents (Lemke and Williams, 
2012).  
Antimicrobial agents are a diverse group of active ingredients and can be categorized 
according to various criteria (Lemke and Williams, 2012): 
• mechanism of action,  
• source, 
• spectrum of activity, 
• application mode, 
• chemical structure.  
 
Antimicrobial agents can be divided based on their mechanism of action and chemical 
structure in different groups.  
• Cell wall synthesis inhibitors 
These inhibitors have the highest selective toxicity, because they inhibit the cell wall 
synthesis which is absent in eukaryotic cells. In this group of inhibitors fall penicillin, 
cephalosporin and glicopeptides (Willey et al., 2008). 
Penicillium is a beta-lactam antibiotic, containing a beta-lactam ring. The mechanism of 
this antibiotic is inhibition of transpeptidase, which is responsible for cross-linkages in 
formation of peptidoglycan. Penicillin binds irreversible to the active site of 
transpeptidase which leads to prevention of new PGN formation and making the cells 
vulnerable to lysis. There are different classes of penicillin’s which differ based on their 
corresponding chemical substitute on the side chain (Lobanovska and Pilla, 2017).  
Cephalosporins have the same mechanism of action as penicillins. They also possess a 
beta-lactam ring in their structure (Sarkar et al., 2017).  
Fosfomycin is a wide-spectrum bacterial antibiotic which interrupts the primary step of 
peptidoglycan synthesis by inhibiting phosphoenolpyruvate synthetase (Ortiz Zacarías 
et al., 2018). It is extremly effective against Gram positive bacteria such as 
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Staphylococcus aureus and Enterococcus sp. and Gram negative bacteria such as E. 
coli, P. aeruginosa and K. pneumoniae (Sarkar et al., 2017).  
 
Figure 2: Bacterial cell wall biosynthesis pathway and inhibitors (Sarkar et al., 2017) 
Slika 2: Biosinteza bakterijske celične steni in njeni inhibitorji (Sarkar in sod., 2017) 
• Protein synthesis inhibitors 
Antimicrobial agents inhibit protein synthesis by binding to prokaryotic ribosomes and 
to fMet-tRNA. They can bind to a smaller 30S subunit or to a bigger 50S subunit of 
ribosomes which leads to direct inhibition of protein synthesis. Their selective toxicity 
is lower than beta-lactam antibiotics, however they can differ between eukaryotic and 
prokaryotic ribosomes.   
Most used inhibitors of protein synthesis are: aminoglycosides, tetracycline, macrolide 
and chloramphenicol (Willey et al., 2008).    
• Nucleic acid synthesis inhibitors 
The antimicrobial agents inhibiting nucleic acid synthesis operate by inhibiting DNA 
polymerase and DNA helicase or RNA polymerase. The selective toxicity of is lower as 
other antibiotics due to a similar synthesis paths of nucleic acids in eukaryotes and 
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prokaryotes. These compounds inhibit the synthesis of precursors (sulphonamides, 
trimethoprim), inhibits DNA replication (quinolones) or inhibits RNA polymerase 
(rifampicin). Quinolones are small synthetic broad spectrum bactericidal antibacterial 
agents. They diffuse easily through the cell wall and can rapidly reach their main target 
DNA gyrase (one of the topoisomerases) (Drlica et al., 2008). 
 
Figure 3: Mechanisms of action of antibiotics (Kapoor et al., 2017) 
Slika 3: Mehanizem delovanja antibiotikov (Kapoor in sod., 2017) 
2.2.1 Antimicrobial resistance (AMR) 
Antimicrobial resistance presents an increasing threat to global public health and the 
need for action is immediate. The impact of antibiotics is now fading manly due to the 
increasing resistance and is clearly seen among all antimicrobial agents (Lobanovska 
and Pilla, 2017). There are many resistant bacterial species to all known antibiotics, 
which makes us susceptible to common infections. Once treatable infectious are 
becoming very difficult to treat, sometimes becoming incurable (Balkhair, 2017). The 
first type of resistance is intrinsic resistance which is controlled chromosomally and is a 
reflection of the properties of the bacterium. The second type is acquired resistance 
which the result of genetic changes that arise with mutations or transfer of genetic 
material (Munita and Arias, 2016).  
The core reasons that lead to antimicrobial resistance are incorrect prescribing, overuse 
and comprehensive use of antibiotics in agriculture and in animal feeds. Moreover, 
globalization, medical tourism, and not sufficient infection control can also contribute to 
the spread of pathogens resistant to antibiotics. Antibiotic resistance can also be 
transferred between gut bacteria, which contains the antibiotic resistance genes known 
as gut antibiotic resistome (Balkhair, 2017). Despite the fact that antibiotic resistance is 
increasing, the global antibiotics research and development has decreased over the past 
30 years (Metz and Shlaes, 2014). This fact is evident by the development of only two 
novel classes of antibiotics in the past three decades, and neither of them applies to 
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Gram-negative bacteria (Michael et al., 2014). The World Health Organization (WHO) 
has notified about the crisis of antibiotic resistance and has published the first list of 12 
bacterial families including pathogens resistant to antibiotics with the biggest risk to 
human health. Three pathogens with severely limited antibiotic options are 
Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacteriaceae which are 
resistant to carbapenem (Balkhair, 2017). 
The AMR crisis occur due to a number of factors (Michael et al., 2014): 
• microbial causes: small size, high adaptability, genetic variability (mutations), 
reproduction of resistant microbes (selective pressure) 
• human causes: rapid growth of human population, overuse of antimicrobials 
• clinical usage: over prescription, entrenched methodologies 
• public perception and behavior (hoarding, non-prescription purchase) 
• agriculture applications 
• commercial pressures 
Mechanisms of resistance  
The fundamental mechanisms of antimicrobial resistance can be intrinsic to species or 
acquired through mutation or horizontal transfer of genes which encodes resistance 
genes.  
Genetic basis of antimicrobial resistance 
The genetic plasticity enables bacteria to acclimate to a broad range of environmental 
threats, even in the presence of antibiotic molecules (Munita and Arias, 2016). Bacteria 
that live in the same ecological niche with the organisms that produce antimicrobials 
evolve intrinsic resistance to live in their presence. From an evolutionary point of view, 
bacteria use two major genetic strategies to adapt to the antibiotics: mutations in genes 
and horizontal gene transfer (HGT).  
a) Mutational resistance 
Mutational resistance occurs when a subset of bacteria from susceptible population 
establish mutations in genes that influence the drug activity, which results in cell 
endurance in the presence of antimicrobials. Bacteria containing the mutation 
predominate, while the susceptible population is eliminated. Mutations which leads to 
antimicrobial resistance impacts the antibiotic via different mechanisms described 
below under mechanistic basis of antimicrobial resistance (Munita and Arias, 2016). 
b) Horizontal gene transfer 
Bacteria acquire external DNA material through horizontal gene transfer which is 
responsible for the development of antimicrobial resistance. Bacteria use three different 
strategies for horizontal gene transfer: transformation, transduction and conjugation 
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(Munita and Arias, 2016). Conjugation is an efficient method of gene transfer by the 
contact between two cells and is often involved in the emergence of resistance in the 
hospital environment. For gene transfer conjugation uses mobile genetic elements such 
are transposons and plasmids, and both have a very important part in the development 
of antimicrobial resistance (Llosa et al., 2002).  
Furthermore, one of the most efficient mechanisms which enables antimicrobial 
resistance genes is site-specific recombination systems transmitted by integrons. 
Integrons represent a simple mechanism which can add new genes into bacterial 
chromosomes (Munita and Arias, 2016).  
Mechanistic basis of antimicrobial resistance 
Bacteria have developed different mechanisms of drug resistance to avoid antimicrobial 
agents. There are multiple biochemical pathways for achieving resistance to one 
antimicrobial class.  
a) Modifications of the antibiotic molecule 
One of the most used strategies to modify antibiotic molecules is the production of 
enzymes that inactivate (chemically alternates) or destroy (production of beta-
lactamases) the antibiotic (Munita and Arias, 2016). 
b) Decreased antibiotic penetration and efflux 
Many of the antibiotics in the use have intracellular bacterial targets and therefore must 
penetrate cell wall in order to reach its target. To prevent the antimicrobial agents to 
reach the intracellular or periplasmic target bacteria have developed different 
mechanisms. They decrease the uptake of the antimicrobial agents by changing the 
permeability of the outer membrane (porin mediated antibiotic resistance) and by efflux 
pumps (Munita and Arias, 2016).  
c) Changes in target sites 
Antimicrobial resistance can be developed by modifications and protection of the target 
site that mark in decreased affinity for the antimicrobial molecule. One of the most 
affected examples by target protection is tetracycline resistant determinants. 
Modification of the target site is one of the most common strategies and it affects almost 
all types of antimicrobial agents. Modifications cover mutations, enzymatic alternation 
and complete replacement of the target site (Munita and Arias, 2016).  
2.2.1.1 Strategies to fight resistance  
One of the new potential strategies to battle antimicrobial resistance is the renewal of 
old antibiotics (Cassir et al., 2014). The pharmacodynamics and pharmacokinetics of 
old antibiotics can be optimized in order to have better outcomes of therapeutics and to 
lower the risk of resistance occurance during the treatment. For clinical revaluation of 
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old antibiotics dosage adjustments and avoidance of other toxic agents are critical. This 
helps reduce adverse effects due to more accurate prescriptions. The reuse of old 
antibiotics exhibits an encouraging strategy to battle antimicrobial resistance, but there 
are still remaining critical points that need further evaluation. Some critical data about 
old antibiotics regarding the rates of resistance and minimal inhibitory concentration are 
missing, since they are hardly included in surveillance programs (Mouton et al., 2011).  
In 2015 WHO has developed a strategic plan which includes five strategies on how to 
prevent or reduce the spread of antibiotic resistance. These five strategies incorporate: 
rising awareness and general understanding of antibiotic resistance, decreasing 
frequency of infection, antimicrobial use optimization, strengthen knowledge, and rising 
investment in new antibiotics. Despite the measures taken by WHO antibiotic use is still 
increasing and in parallel also the antimicrobial resistance (Zaman et al., 2017).  
2.3 BACTERIAL CELL WALL  
Bacterial cell wall is an important morphological element that gives the cell a shape, 
makes it rigid, mechanically solid, and allows the maintenance of osmotic pressure of 
the cell (Cabeen and Jacobs-Wagner, 2005). Furthermore, it also represents a protection 
against lysis and environmental factors (Smith, 2006). Cell wall acts as semi permeable 
membrane and allows the transport of the desired substances only. It is located on the 
outer side of the cytoplasmic membrane and it is involved in the cell division and 
growth process (van Heijenoort, 2001).The cell wall can be found in all types of 
bacteria, except for mycoplasmas, some rickettsia, and chlamydia (Vollmer et al., 
2008).   
The structure of the bacterial cell wall defines two groups of bacteria. The 
differentiation is based on the different coloring of bacteria using Gram’s method of 
staining. This method is used to distinguish between Gram positive (blue) and Gram 
negative (red) bacteria. Gram staining differentiates bacteria by recognizing 
peptidoglycan in the cell wall, which is present in Gram-positive bacteria in a larger 
amount than in the Gram-negative bacteria (Cabeen and Jacobs-Wagner, 2005). 
The cell wall of Gram-positive is assembled of up to 40 layers of peptidoglycan, with 
the thickness of 15-50 nm. Peptidoglycan represents 50 % of the cell wall, the other 
proportion is divided between acidic anionic polymers (teichoic and lipoteichoic acid) 
representing 40-45 % of the cell wall and the other 5-10 % being proteins and 
polysaccharides (Cabeen and Jacobs-Wagner, 2005). Teichoic acid is a bound 
covalently to peptidoglycan in Gram positive bacteria and is a polymer of glycerol 
phosphate and ribitol phosphate. Lipoteichoic acid is a polymer bound to a lipid that 
allows interaction with the cytoplasmic membrane (Percy and Gründling, 2014). 
The cell wall of Gram negative bacteria is more complexed and thinner (1-7 nm). It is 
made of a thiner layer of peptidoglycan representing 10 to 20 % of the cell wall mass 
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and is pierced with lipoprotein molecules (Black, 2012). The outer membrane represents 
the lipid bilayer, consisting of porins and lipoproteins. Porins are a class of proteins 
which act as a pore and form channels through membrane and are responsible for 
transportation of hydrophilic molecules, including antibiotics. The other compound 
lipoproteins link peptidoglycan and the outer membrane. A unique outer membrane 
molecule of Gram negative bacteria is lipopolysaccharide (LPS). LPS are a source of 
heat stable endotoxins and have are able to activate a strong immune response (Yücel et 
al., 2017).  
2.4 PEPTIDOGLYCAN 
Peptidoglycan is a polymer which surrounds the bacterial cell. Its main functions are 
retaining the integrity of the cells and preventing lysis due to the osmic pressure 
(Banzhaf et al., 2012). Nowadays the biggest challenge in research present the constant 
development of novel antibiotics. Therefore, the biosynthesis pathway of peptidoglycan 
present one of the best sources of targets for the development of novel classes of 
antimicrobial agents (Francisco et al., 2004).  
2.4.1 Structure of peptidoglycan  
The composition of peptidoglycan is similar in Gram negative and Gram positive 
bacteria, the difference being that the cell wall of Gram positive bacteria has multiple 
peptide bridges and is thicker than Gram negativebacteria (Smith, 2006). 
The basic peptidoglycan structure is composed of linear glycan chains connected by 
strands of short cross-linking peptides (Smith, 2006). Units of N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) residues are linked by β-(1,4)-
glycosidic bonds and form glycan chains. MurNAc residues are attached to amino acid 
chains. There are two types of cross-linking of the glycans. Generally, the most frequent 
one is between the amino group of the diamino acid and the carboxyl group of D-Ala, 
which can occur directly or through a short peptide bridge. The second cross-linking 
method is found only among coryneform bacteria occurs between the carboxyl group of 
D-Ala and α-carboxyl group of D-Glu of one peptide chain. The cross linking is 
catalysed by the transpeptidase domain of penicillin-binding proteins (PBP) (Vollmer et 
al., 2008). 
Notwithstanding all the data known on the structure of peptidoglycan, the three-
dimensional structure is still not fully known. There are two existing theories; the first 
says that the glycan chains are placed in parallel to the bacterial cytoplasmic membrane, 
and second one is that the chains are orthogonal to the membrane (Meroueh et al., 
2006). 
The structure described above applies to most bacteria, but there are still differentiations 
among individual bacteria in the composition of the peptide chain, the length of glycan 
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chains and cross-linking method. Specificity of Mur ligases and reactions in the 
consecutive stages of biosynthesis of peptidoglycan define the composition of glycan 
chains (Vollmer et al., 2008). 
 
Figure 4: Structure of peptidoglycan in E. coli (Vollmer et al., 2008) 
Slika 4: Struktura peptidoglikana E. coli (Vollmer in sod., 2008) 
2.4.2 Biosynthesis of peptidoglycan  
The growth of peptidoglycan is a complex multi-stage process and it involves 
approximately 20 enzymatically catalyzed reactions (Figure 2). The biosynthesis is 
divided into three phases: cytoplasmic, membrane and periplasmic (Barreteau et al., 
2008). The first phase is carried out in cytoplasm where the nucleotide precursors and 
UDP-MurNac-pentapeptide are synthesized. On the cytoplasmic side of the membrane 
the synthesis of monomers of GlcNAc-MurNAc-pentapeptide linked to undecaprenyl 
phosphate occur, which are polymerised and cross bound on the outer side of the 
membrane (Nikolaidis, 2015).  
The cytoplasmic phase of peptidoglycan synthesis is split into four steps: 
1.) biosynthesis of UDP-N-Acetylglucosamine (UDP-GlcNAc)  
The biosynthesis of UDP-GlcNAc from fructose-6-phosphate is carried out using three 
enzymes. It begins with the biosynthesis of Glc-6-phosphate from fructose-6-phosphate, 
which is catalyzed by glucosamine-6-phosphate synthetase (GlmS), followed by 
isomerization of glucosamine-1-phosphate catalyzed by phophoglucosamine mutase 
(GlmM) and ultimately in the last step UDP-GlcNAc is synthesized and it is catalyzed 
by glucosamie-1phosphate acetyltransferase and N-acteilglucosamine-1-phosphate 
uridiltransferase. The UDP-GlcNAc biosynthesis is also performed in eukaryotic cells, 
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but in a different way, and this stage of biosynthesis of peptidoglycan also offers 
possible targets for well-selective toxic antibacterial agents (Barreteau et al., 2008) 
2.) biosynthesis of UDP-MurNAc 
The synthesis of UDP- N-Acetylmuramic acid (UDP-MurNAc) from UDP-GlcNAc 
requires two steps. The first step is catalysed by MurA ligase which transfers 
enolpyruvate from phosphoenolpyruvate (PEP) to the 3’-hydroxyl of uridine diphospho-
N-acetilglucosamine (UDP-MurNAc) generating enolpyruvyl-UDPN-
acetylglucosamine and inorganic phosphate (Pi) (Gautam et al., 2011b). Reduction 
reaction of UDP-GlcNAc-enol-pyruvate is catalysed by MurB and present the second 
step of pepetidoglycan’s biosynthesis. (Meroueh et al., 2006). 
3.) synthesis of pentapeptide and the forming of UDP-MurNAc-pentapeptide  
The third step of cytoplasmic phase is the biosynthesis of UDP- N-Acetylmuramic-
pentapeptide (UDP-MurNAc-pentapeptide) from UDP-MurNAc, which is catalyzed by 
four Mur ligases. MurC, MurD, MurE and MurF add the chain of five amino acid to 
carboxyl group of D-lactate in UDP-MurNAc and catalyze the forming of the amide 
bond between amino acids to form the L-Ala-D-Glu-mDAP (L-Lys) -D-Ala-D-Ala 
chain. 
4.) formation of D-Glu and dipeptide D-Ala-D-Ala  
The fourth step in cytoplasmic phase are side reactions. In this phase occurs the 
formation of D-Glu from L-Glue catalyzed by glutamate racemase (MurI) and D-Ala 
from L-Ala catalyzed by alanine racemase (Alr) and the synthesis of the D-Ala-D-Ala 
dipeptide catalyzed by D-alanine ligase (DdI) (Barreteau et al., 2008). Following the 
cytoplasmic phase is the binding of precursors to the lipid carrier and transmission 
through the cytoplasmic membrane. UDP-MurNAc-pentapeptide binds to the 
phosphorylated lipid carrier with the help of MraY (phospho-MurNAc-pentapeptide 
translocase) integral membrane enzyme and forms UMP and undecaprenyl-pyro-
phosphoryl-MurNAc-pentapeptide. Furthermore, MurG catalyses the addition of 
GlcNAc followed by the formation of undecaprenyl-pyro-phosphoryl-MurNAc- 
(pentapeptide) -GlcNAc (Bouhss et al., 2008). Fromation of the lipid II is the last 
intracellular product in the synthesis of peptidoglycan. Lipid II is transferred to the 
outer side of the cell membrane is caalysed by FtsW enzyme (Mohammadi et al., 2011).  
The last third phase of peptidoglycan biosynthesis is carried out on the outer side of the 
bacterial membrane, where the polymerization of precursors and binding to existing 
peptidoglycan occurs. Once lipid II is transferred to the periplasmic side of the 
membrane the penicillin binding proteins (PBP) help to incorporate it into the 
peptidoglycan (Macheboeuf et al., 2006). The first step of last phase is the association 
of sugar units in prolonged glycanic fibers (transglycosylation). They form a β (1-4) 
glyosidic bonds between the GlcNAc-MurNAc-pentapeptide, which is bound to the 
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lipid carrier, and the existing glycan chain. During this reaction the undecaprenyl 
pyrophosphate molecule is released and transferred to the inner side of the membrane 
where it is dephosphorylated. In the last step the transpeptidase domain of PBP 
recognizes and binds to the D-Ala-D-Ala fragment of the pentapeptide chain and cuts 
the terminal D-Ala. The peptide bond is then formed among the remaining D-Ala, 
which reacts with the ε-amino group of mDAP or L-Lys of the adjacent glycan chain. 
Thus, the final transverse connection between two adjacent glycan chains is formed 
(Sauvage et al., 2008). 
 
Figure 5: Cytoplasmic steps of biosynthesis of peptidoglycan (Barreteau et al., 2008) 
Slika 5: Citoplazemska faza sinteze peptidoglikana (Barreteau in sod., 2008)  
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2.5 SUPERFAMILY OF MUR LIGASES 
Mur enzymes are ATP-dependent ligases and the essential in biosynthesis pathway with 
a high potential to become targets for new classes of antibacterial agents (Kouidmi et 
al., 2014). Mur ligases consist of common structural motifs and are highly conserved 
among various bacterial species. Thus, this present the main reason why novel 
inhibitors would be expected to have a wide bactericidal spectrum (El Zoeiby et al., 
2003).  
 
Mur ligases are composed of three domains: (Barreteau et al., 2008): 
• N-terminal domain (for UDP-precursor binding), 
• central domain (for ATP binding), 
• C-terminal domain (for amino acid or dipeptide binding). 
The enzymatic mechanism is similar in all Mur ligases. They activate the free carboxyl 
group of UDP precursor using γ-phosphate group of ATP and form ADP and acyl-
phosphate intermediate. Amino acids bind to an acyl-phosphate intermediate forming a 
phosphorylated tetrahedral intermediate. Following the elimination of phosphate and the 
formation of peptide bond (Hiratake, 2005). 
2.5.1 MurA 
The MurA (N-acetylglucosamine enolpiruvil transferase) enzyme catalyzes the first step 
of the peptidoglycan biosynthesis. MurA takes part in a rare biochemical process, which 
transfers enolpyrovyl group from phosphoenolpyruvate (PEP) to an OH group UDP-
GlcNAc (Figure 6). 
 
Figure 6: Enzymatic reaction of MurA (Gautam et al., 2011a) 
Slika 6: Encimska reakcija MurA (Gautam in sod., 2011a) 
Mur enzymes are very important and conserved between different types of bacteria. The 
difference in MurA between Gram negative and Gram positive bacteria is in the number 
of the copy of murA gene. Gram positive bacteria have two copies of murA gene 
(murA1 and murA2), probably arisen from gene duplication while Gram positive 
bacteria have one copy (Barreteau et al., 2008). Enzyme MurA is also vital enzyme for 
the growth of the cell and the deletion of murA gene is leather to the bacterium. 
Therefore, it is predictable for the potential Mur inhibitor to demonstrate bactericidal 
Rustemi E. Antimicrobial potential of actinobacterial inhibitors of Mur ligases in bacterium C. difficile.  
  M.Sc. Thesis (Du2). Ljubljana, Univ. of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
 
17 
 
activity in a broad spectrum. This confirms the importance of ths enzyme as target for 
the search for novel antibacterial agents (El Zoeiby et al., 2003). 
2.5.2 MurB 
MurB enzyme (UDP-N-acetylenolpyruvylglucosamine reductase) is a 38-kDa protein 
which consists of three different domains. Domain one and two moderate the binding of 
flavin adenine dinucleotide (FAD) and the domain three is responsible for the binding 
of its substrates (Barreteau et al., 2008). The structural elements in MurB distinguish 
between Gram positive and Gram-negative bacteria. MurB belongs to the FAD-binding 
protein superfamily, which is divided into at least two groups by amino acid sequence 
alignment: type I and type II. However structural analyses with X-ray indicate that 
MurB proteins in both types have a similar overall fold, despite the differences between 
the substrate binding sites, which occur due to acid deletions (Nishida et al., 2006). 
MurB catalyses the reduction reaction of UDP-N-acetylglucosamine enolpyruvate to 
UDP-N-acetylmuramic. It contains one molecule of non-covalently bound FAD. FAD is 
a cofactor that is reduced to FADH2 by two electron transfer from NADPH. The two 
electrons from the reduction reaction are transferred to the C-3 of the enolpyruvyl group 
(El Zoeiby et al., 2003). The reduction reaction is carried out in two half reactions. The 
first half reaction begins with the binding of NADPH to MurB which catalyzes the 
transfer of the H+ of NADPH to N-5 of the FAD. Other half of reaction is carried out by 
FADH2  which is responsibe for the reduction of vinylic enol ether (Barreteau et al., 
2008). 
2.5.3 MurC 
MurC (UDP-MurNAc: L-alanine ligase) ligase catalyzes the addition of the first amino 
acid (usually L-alanine or rarely L-serine) to the peptide chain. L-alanine is attached to 
the D-lactyl group of UDP-MurNAc resulting in the formation of UDP-MurNAc-L-Ala 
(UMA) (Spraggon et al., 2004). MurC enzyme is assembled of three structural domains, 
the active site of the enzyme lies at the juncture of the three domains. N-terminal 
domain is composed of five central parallel β-structures and is responsible for binding 
of UDPMurNAc substrate. Followed by the biggest central domain containing seven 
central mostly parallel β-structures, which interacts with ATP. Amino acid (L-alanine) 
is bound by the help of C-domain (Smith, 2006). 
2.5.4 MurD 
Ligase MurD (UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase) catalyses the 
attachment of D-glutamic acid forming UDP-N-acetyl-muramoyl-L-alanine-D-
glutamate (UMAG). The composition of MurD is similar to other Mur ligases with 
three globular domains. N-domain has a dinucleotide binding site for the binding of 
UDP part of the substrate. Central domain initiates the binding of ATP. Following the 
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last C-terminal domain which contains the binding site for D-glutamic acid. MurD 
ligase was the first of the Mur ligases with a resolved crystal structure. It was isolated 
from E. coli in the UDP-MurNAc-L-Ala complex (Perdih et al., 2009).  
2.6 INHIBITORS OF MUR LIGASES 
The increasing number of antibiotic resistant bacteria and the search for new treatment 
of bacterial infections, has prompted the interest in the development of novel potential 
inhibitors of existing targets (Galley et al., 2014). In the context of developing novel 
bacterial inhibitors biosynthesis of peptidoglycan has been, for the past five decades, a 
preferred target. There has been identified inhibitors for enzymes that catalyze each 
stage of peptidoglycan biosynthesis, although not all are applicable for clinical use.  
However, most of these antimicrobial agents are inactive in the bacteria with resistant 
mechanisms. The understanding of these mechanisms has become crucial as part of the 
development of new antimicrobials (Nikolaidis, 2015). Mur enzymes are well 
characterized both structurally and enzymatically and are conserved and specific to 
bacteria becoming potential target for novel antibacterial (Meroueh et al., 2006).Many 
antibiotics in use have been developed (β-lactams and glycopeptides), which inhibit the 
last step of peptidoglycan biosynthesis, however this has not stopped the emerging of 
resistant bacteria. For this reason, in the last decades the interest in the initial phases of 
peptidoglycan biosynthesis has increased (El Zoeiby et al., 2003). 
2.6.1 Inhibitors of MurA 
2.6.1.1 Fosfomycin 
The initial cytoplasmic steps of peptidoglycan biosynthesis are not sufficiently 
considered as targets for antibacterial agents, as only one inhibitor, fosfomycin is 
applicable in clinical use. Therefore, MurA which catalyzes the first step of bacterial 
peptidoglycan biosynthesis, is a potential candidate for novel therapeutic intervention. 
As mentioned, is fosfomycin the only known antibiotic to target MurA. Fosfomycin is a 
PEP mimic natural product produced by Streptomyces (Bensen et al., 2012). It 
covalently binds to the conserved cysteine residue Cys115 and irreversibly inactivates 
it. There are two available formulations for oral application– fosfomycin tromethamine 
(soluble salt) and fosfomycin calcium. The first formulation as tromethamine is a 
preferred one due to the rapid absorption into the blood Mechanism of action of 
fosfomycin is similar in Gram positive and Gram negative bacteria. It enters the cells of 
bacteria using two different transport systems a constitutively functional L-a-
glycerophosphate transport system (GlpT) and the hexose–phosphate uptake system 
(UhpT) (Michalopoulos et al., 2011).  
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Figure 7: Chemical structure of fosfomycin (Michalopoulos et al., 2011) 
Slika 7: Kemična struktura fosfomicina (Michalopoulos in sod., 2011) 
Fosfomycin has a broad antimicrobial activity against Gram positive and Gram negative 
bacteria.  
2.6.1.1.1 Resistance mechanisms to fosfomycin  
There are three resistance mechanisms to Fosfomycin. Two are located on the 
chromosome and one is located on the plasmid. Resistance against fosfomycin can be a 
result of a mutation in chromosomally encoded transport systems or as a result of 
modification of fosfomycin leading to its inactivation. Resistance encoded in plasmid 
occurs due to the modification of antibiotic molecule by enzymes (FosA, FosB, FosC 
and FosX). Some examples of fosfomycin resistance have been described during these 
years. MurA from E. coli, which contains the C115D mutation, is enzymatically active 
but resistant to fosfomycin inhibition (Zhu et al., 2012). In contrast, MurA from H. 
influenzae, which has Cys117 replaced with alanine or serine, completely loses its 
catalytic activity. This gene is necessary for the MurA to function properly (Han et al., 
2013). Some bacteria are naturally resistant to fosfomycin due to Cys115 in MurA 
being replaced with asparagine acid. Examples of such resistance are the following 
bacteria: Chlamydia trachomatis, Borrelia burgdorferi, Vibrio fischeri and 
Mycobacterium tuberculosis (Michalopoulos et al., 2011). In the past years the series of 
novel inhibitors against MurA have been discovered, however they are not applicable in 
the clinical use (Gautam et al., 2011a).  
 
Figure 8: Resistance mechanisms against fosfomycin (Nikolaidis et al., 2014) 
Slika 8: Mehanizmi resistance proti fosfomicinu (Nikolaidis in sod., 2014) 
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Furthermore, other novel inhibitors were reported such as benzothioxalone derivates. 
These new inhibiotrs have been identified by using high throughput screening (HTS). 
Moreover, chemically synthesized inhibitors cyclic disulphide, a pyrayolopyrimidine 
and purine were discovered. These inhibitors show a higher efficiency than fosfomycin 
in a lower MIC. Other derivates worth mentioning are sulfonyloxy anthranilic acid 
derivates, imidayole derivates, aminotetraone derivates prptide derivates and 
sesquiterpene lactones derivates (cnicin and cynaropicrin). Miscellaneous inhibitors 
have shown inhibitory activity against H. influenza MurA. They bind to the active site 
of MurA in closed conformation which differ them from Fosfomycin as it binds to the 
active site of MurA in open confiramiton (Sangshetti et al., 2017). 
 
2.6.2 Inhibitors of MurB 
MurB presents an attractive target for new inhibitors mainly due to the deficiency of the 
homologue in eukaryotic cells. The search for MurB inhibitors has generated several 
hits even though none of the molecules could demonstrate to target MurB specifically in 
vivo (Nikolaidis et al., 2014). In the early 2000s a first novel class of 4-thiazolidinone 
inhibitors against MurB was identified. They were produced to mimic the diphosphate 
moiety of UDP-Glc-NAc-enolpyruvate (Andres et al., 2000). Following this study in 
2002 another inhibitor of MurB enzyme was discovered. They discovered a heterocyclic 
replacement for the thiazolidinone. These new imidazolinone analogues inhibitors 
despite the ability to inactivate MurB also demonstrate the potential of a whole cell 
antibacterial activity, representing a promising chemotype in the search for novel 
antimicrobial agents (Bronson et al., 2003). A decade later a study of a research for new 
inhibitor against MurB was conducted. They reported the design and synthesis of a new 
1,2,4-triazole-based thiazolidin-4-one hybrids and has opened the door for developing 
more useful thiazolidinone analogues (Ahmed et al., 2016). Moreover, other derivates 
identified as potential MurB inhibitors are 3,5-dioxopyrazolidines, which show 
inhibitory activity against bacterial strains resistant to antibiotics. Their mechanism of 
action is binding to the active site of MurB blocking the binding of FAD cofactor. 
Futhermore, these derivates show multi target inhibitory effect against MurA, MurB and 
MurC enzymes as inhibitors of MurB can bind to active sites of other two mentioned 
Mur enzymes (Sangshetti et al., 2017). 
2.6.3 Inhbitors of MurC 
As potential MurC inhibitors phosphinate analogues of the tetrahedral transition state, 
benzylidenerodanine inhibitors, benzofuran acilsulfinamides and pulvinones were 
discovered (Barreteau et al., 2008). Benzylidenerodanine inhibitors are active against 
methicillin resistant S. aureus (MRSA), but not against E. coli. Phosphinate inhibitors 
are phosphorylated with the help of ATP and mimic the tetrahedral transition state, 
which occurs in a normal process of formation of peptide bond (Reck et al., 2001).  
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The following potential inhibitors of the MurC enzyme are benzylidene rhodanines 
derivates. For the inhibitory action of these analogues, a free NH group is required 
which forms hydrogen bonds with the active site of the enzyme. The inhibitors were 
tested on bacterial cells and the results of some analogous showed to inhibit Gram 
positive bacteria such is S. aureus (MRSA). However, none of the inhibitors work 
against Gram negative E. coli (Sim et al., 2002). Furthermore, pyrazolopyrimidines 
derivates are reported as inhibitors of MurC ligases (Sangshetti et al., 2017). 
 
2.6.4 Inhibitors of MurD 
To date, several inhibitors of the MurD enzyme have been developed. MurD is the first 
enzyme for which carbonate and amide substituted phosphynate inhibitors were 
conducted (El Zoeiby et al., 2003). Subsequently, the derivatives of pulvion, pyrazole 
and peptide inhibitors, compounds with the N-acetylhydrazone fragment and 
macrocyclic inhibitors were also discovered (Sosič et al., 2011). The newer inhibitors 
discovered are enhanced glutamic acid containing 5-benzylidenethiazolidin-4-one and 
5-benzylidenerhodanine inhibitors, which were synthesized according to the crystal 
structure of the MurD (Zidar et al., 2011). Furthermore, naphthalene-N-sulfonyl-D-
glutamic acid, n-sučfonyl glutamic acid, coumarin and polycyclic derivates are reported 
as inhibitors of MurD. Different compounds of the mentioned derivates were tested and 
their inhibitory effect was presented in detail. Novel potential inhibitors against MurD 
ligase are macroclic inhibitors, which are synthesiyed usig computer based technique of 
molecular designing (Sangshetti et al., 2017) 
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2.7 RECOMBINANT PROTEIN EXPRESSION 
Developments in the area of recombinant protein expression for structural and 
biophysical studies, biomarkers, functional assays, for the use as therapeutics in pharma, 
biotech and academia has steadily increased over the last years. The three main most 
common expression systems in use are: E. coli, insect cell expression using Baculovirus 
Expression Vector System (BEVS) and mammalian cells for the expression of stable 
and transient recombinant proteins (Assenberg et al., 2013). 
2.7.1 Escherichia coli expression system  
Escherichia coli is one of the most widely used expression systems for heterologous 
proteins. The use of E. coli is well established and most popular for many reasons: it 
offers rapid culture times and the ability to produce high biomass and high protein 
yields and it is inexpensive (Rosano and Ceccarelli, 2014). The availability of an 
increasing number of cloning vectors and mutant host strain make it also the most 
attractive system to use. 
Between microorganisms there are many host systems available including bacteria, 
filamentous fungi, yeast, and unicellular algae. The advantages for using E. coli as an 
expression host are well known. E. coli has fast growth kinetics, its doubling time is 20 
minutes, which mean that a diluted bacterial culture can reach stationary phase in few 
hours. High cell density cultures can be easily achieved using optimal growth media 
reaching 1x1013 viable bacteria/ml. However, this number does not apply using complex 
media which can be made from already available and inexpensive compounds. Another 
advantages for using E. coli is fast and easy transformation with exogenous DNA 
(Rosano and Ceccarelli, 2014).  
The right choice of plasmid is also important in the expression. The main expression 
plasmid used are the result of different combinations of replicons, promoters, selection 
markers, multiple cloning sites and fusion protein removal strategies. A copy number is 
a very important parameter when choosing the right vector. The high copy number 
plasmids for protein expression do not result in an increase production yields, because it 
may be a metabolic burden which can cause a decrease in bacterial growth. Most 
common used vectors are pET and pUC series. In the vector pET the T7 promoter 
system is present. Plasmid must also include a selection marker to eliminate the plasmid 
free cells. For the E. coli antibiotic resistance genes are usually used. However, the cost 
of using antibiotics as a selection marker in a large-scale culture is a big concern leading 
them to develop an antibiotic-free plasmid system. Affinity tags are added to N-terminal 
or C-terminal end of a vector when a purified soluble active recombinant protein is 
needed. Examples of small peptide tags are poly-Arg-, FLAG-, poly-His-, c-Myc, S-, 
and Strep II-tags. The tagged recombinant proteins can be detected by Western blot or 
by SDS-page (Rosano and Ceccarelli, 2014).  
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There are many suitable E. coli strains to use as a host and all of them have advantages 
and disadvantages. Most common strain of E. coli used as a host is BL21 (DE3). The 
BL21 strain have many genetic characteristics making it suitable for the expression such 
as deficiency in Lon protease, which is responsible for degrading foreign proteins, 
protease OmpT, whose function is to degrade extracellular proteins. They contain a 
mutation in the hsdSB gene, resulting in the disruption of DNA methylation and 
degradation.   
Expression in E. coli has also some disadvantages. For example, expression proteins 
that are more mammalian like require some additional modifications and strategies. One 
of the approaches to induce disulphide formation is addition of a signal peptide to the 
N-terminus of the recombinant protein, increasing the level of the translocation 
complex, altering the cytoplasmic environment to a more oxidizing one use of 
osmolytes and chemical chaperones (Assenberg et al., 2013). 
Different strategies have been implemented to overthrow typical obstacles that occur 
during recombinant protein expression in E. coli. There are three major issues regarding 
the protein expression in E. coli. First obstacle that can occur is no or low expression, 
which can be a result of protein being toxic before induction. The solution for this is 
control of basal induction by adding glucose when using vector containing lac-based 
promotors, use defined media with glucose as a carbon source or use promotors with 
tighter regulation. Another explanation for a low or no expression is that protein is toxic 
after the induction, which can be solved using a lower plasmid copy number and with 
controlling the level of induction. Codon bias can also be a possible explanation for the 
first problem, solving it with optimization of codon frequency in cDNA, use codon bias-
adjusted strain and increase biomass. The second obstacle is inclusion body formation 
(IB). IB can be the result of incorrect disulphide bond formation or incorrect folding. 
Some of the solutions for overcoming the first cause of this problem is to use E. coli 
strains with oxidative cytoplasmic environment or direct protein to the periplasm and 
solution for incorrect folding is to remove inducer and add fresh media or lower 
production rate. The third obstacle that can occur is protein inactivity. Possible 
explanations for this problems are: low solubility of the protein (solving it with the use 
of fusion patterns), essential post translational modification is needed (need to change 
the microorganism), incomplete folding (lower the temperature of expression, monitor 
disulphide bond formation and allow further folding in vitro) and mutations in cDNA 
(sequence plasmid before and after induction, use a recA- strain to ensure plasmid 
stability or transform E. coli before each expression round) (Rosano and Ceccarelli, 
2014).  
2.7.2 Baculovirus expression vector system in insect cells  
Expression in insect cells using Baculovirus (BV) technology has become a routine 
implementation for recombinant protein production. Two methods are used for 
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expression in insect cell: transposition of recombinant Baculovirus in vivo in E. coli 
(commercialized as the Bac-to-Bac® system) and in vivo recombination in insect cells 
(Assenberg et al., 2013).  
2.7.2.1 Insect cells 
The most used cell lines for the Baculovirus expression of vector system are Spodoptera 
frugiperda (Sf9 and Sf21 cell line) and Trichoplusia ni. Sf9 is usually the most 
extensively used and was primarly retrieved from ovarian tissue of the fall armyworm. 
2.7.2.2 Baculovirus  
Recombinant baculoviruses are extensively used in large-scale application to express 
heterologous genes in insect cells and insect larvae. Baculovirus are a family of insect 
viruses with a double-stranded, circular, supercoiled DNA molecule in a rod-shaped 
capsid. The most commonly used vectors for expression of heterologous protein is 
Autographa califrnica mononuclear polyhedrosis virus and Bombyx mori (silkworm) 
nuclear polyhedrosis virus. This virus is well established for cultured cells such as 
Spodoptera frugiperda (Sf) lines 9 and 21 and Trichoplusia ni cells. The replication 
cycle of the virus is divided into three phases: immediate-early, early and late phase. 
The Baculovirus expression strategy takes advantages of the late phase protein 
production of polyhedrin protein. The gene for the production of polyhedron can be 
replaced by the foreign gene of interest controlled by polyhedron promotor which 
results in a high level of protein production (Schneemann and Young, 2003).  
2.7.2.3 Recombinant virus by site-specific transposition (Bac-to-Bac® TOPO® 
Expression System) 
Site-specific transposition with Tn7 is used for a rapid production of recombinant 
baculovirus uses site-specific. Foreign genes are introduced to bacmid DNA which is 
propagated in E. coli. The first step is cloning of the gene of interest into the 
pFastBac™ vector, forming a recombinant plasmid which is transformed to the 
competent DH10Bac™ cells. Comptenet cells contain the parent vector bacimid with 
encoded lacZ-mini-attTn7 fusion and a helper plasmid. The transposition proteins are 
provided by the helper plasmid in order for the mini-Tn7 element to be transposed to the 
to the mini-attTn7 target site on the bacmid. Identification of the recombinant colonies 
is based on the antibiotic selection and blue/white screening. The latter occurs due to 
disruption of the lacZ gene during the transposition. After selection of the E. coli clones 
containing the recombinant bacmid the high molecular weight DNA is prepared and 
used for the transfection of insect cells.  
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Figure 9: Flowchart outlining the steps for the production of recombinant Baculovirus using Bac-to-
Bac™ expression (ThermoFisher, 2019) 
Slika 9: Stopnje produkcije rekombinantnega baculovirusa z uporabo sistema Bac-to-Bac™ 
(ThermoFisher, 2019) 
 
Many different varieties of pFASTBAC donor plasmids are used. The plasmid 
pFASTBAC 1 is applicable for the expression of unfused recombinant proteins. 
Furthermore, pFASTBAC HT vectors express poly-His-tagged proteins following the 
simple and fast purification step. The pFASTBAC DUAL vector is applicable for the 
expression of two genes. The expression of two genes is possible because the vector 
contains two promoters (polyhedron promoter and p10 promoter) and the cloning sites 
(ThermoFisher, 2019).  
 
Two major adventages of site-specific transposition comparing to homologous 
recombination can be highlighted (ThermoFisher, 2019): 
• Faster-one step purification and amplification, easier identification (isolated 
recombinant virus DNA is not mixed with nonrecombinant parental virus). 
• Rapid isolation of multiple recombinant viruses which is suited for expressing 
protein variants for structure/fusion studies.  
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3 MATERIAL AND METHODS 
3.1 MATERIALS 
3.1.1 Bacterial strains 
3.1.1.1 Clostridium difficile strains 
For the research work 8 strains of C. difficile isolates received from the Culture 
Collection of Switzerland (CCOS) were used. 
Table 1: List of eight C. difficile strains  
Preglednica 1: Seznam osmih bakterijskih sevov C. difficile  
Clostridium difficile strains 
CCOS-871 
CCOS-876 
CCOS-877 
CCOS-937 
CCOS-938 
CCOS-940 
CCOS-957 
CCOS-958 
3.1.1.2 Escherichia coli strains 
Table 2: List of different competent cell type 
Preglednica 2: Seznam različnih tipov kompetentnih celic 
E. coli strains Genotype Producer Serial 
number 
BL21 Competent E. 
coli 
fhuA2 [lon] ompT gal [dcm] ΔhsdS New 
England 
Biolabs, 
Inc  
C2530H 
BL21(DE3) 
Competent E. coli 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS; λ DE3 = λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 
∆nin5 
New 
England 
Biolabs, 
Inc  
C2527I 
DH10Bac™ 
Competent Cells 
F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139 
Δ(ara, leu)7697 galU galK λ-
rpsL nupG/pMON14272/pMON7124 
Thermo 
Fisher 
Scientific 
1036101
2 
NEB® 10-beta 
Competent E. coli  
Δ(ara-leu) 7697 araD139  fhuA ΔlacX74 galK16 
galE15 e14-  ϕ80dlacZΔM15  recA1 relA1 endA1 
nupG  rpsL (StrR) rph spoT1 Δ(mrr-hsdRMS-mcrBC)  
New 
England 
Biolabs, 
Inc  
C309I 
TOP10 Chemically 
Competent E. coli 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
Δ lacX74 recA1 araD139 
Δ( araleu)7697 galU galK rpsL (StrR) endA1 nupG 
Thermo 
Fisher 
Scientific 
C404010 
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3.1.2 Synthetic DNA (Mur ligases)  
Codon optimized synthetic Mur DNA (MurA, MurB and MurC) for expression in 
Eschericia coli and insect cells were ordered from GeneArt (Thermo Fisher).  
As a proof of concept MurD was used as a positive control. The construct 
pET28a::murD was provided by David Frasson (ZHAW). MurD DNA sequence was 
ordered codon optimized for overexpression in E. coli and insect cells.   
Table 3: Codon optimized mur genes  
Preglednica 3: Kodon optimizirani geni mur ligaz 
Gene name Gene size [bp] Producer CONSTRUCT ID 
MurA 1284 Thermo Fisher Scientific 18ABTJYP 
MurB 966 Thermo Fisher Scientific 18ABTUVP 
MurC 1365 Thermo Fisher Scientific 18ABTUUP 
3.1.3 Insect cells 
Sf9 cell line from Spodoptera frugiperda was used as expression host for the production 
of protein products genetically manipulated into Baculovirus vector system (pFastBac 
Dual) and it was obtained from Thermo Fisher. 
3.1.4 Plasmids 
3.1.4.1 pET28 
pET28 is an expression vector of the size 5369 bp containing kanamycin resistance. It is 
a low copy plasmid, which carries T7 lac promoter, N-terminal and C-terminal His-tag, 
thrombin cleavage site, internal T7 epitope tag and multiple cloning site. In this study 
pET28 was used for the cloning and expression of recombinant proteins in E. coli.  
3.1.4.2 pFastBac®  
pFastBac is a high copy expression vector of the size 4800 bp used for the expression of 
recombinant proteins in insect cells. It carries ampicillin resistance; high level of 
recombinant protein production is controlled by polyhedrin promotor. Furthermore, it 
has encoded the lacZ gene for visual blue-white screening.  
3.1.4.3 pMA 
pMA-T is a 2374 bp vector with encoded ampicillin resistance. Plasmid contains a T7 
promoter and multiple cloning site polylinker.  
3.1.4.4 pSIL 
pSIL is a high copy expreesion vector of the size 6883 bp. It is derived from pFASTBac 
Dual expression vector with encoded ampicillin resistance. Plasmid contains 
polyhedron promotor which controls the synthesis of cloned Mur ligases and p10 
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promotor which controls RFP expression. For this research work pSIL containing the 
red fluorescence protein (RFP) was used in order to control the expression of proteins 
under microscope.  
3.1.5 Culture media  
3.1.5.1 Liquid LB (Luria Broth) medium 
LB culture medium was prepared in a glass bottle by mixing 10 g/l of tryptone, 5 g/l of 
yeast extract and 5 g/l of NaCl dissolved in 500 ml distilled water. The medium was 
sterilized in autoclave at 121°C for 15 min and was stored at 4°C. In some procedures, it 
was necessary to add a predetermined concentration of a specific antibiotic in the LB 
medium. 
Table 4: Stock and final concentration of antibiotics in LB media 
Preglednica 4: Založne in končne koncentracije antibiotikov v LB gojiščih 
Antibiotic Stock concentration (mg/ml) Final concentration (μg/ml) 
Ampicillin 100 100 
Chloramphenicol 34 35 
Gentamycin 7 15 
Kanamycin 10 10 
Tetracycline 1 10 
3.1.5.2 Solid LB medium 
Solid LB medium was prepared in a glass bottle by mixing 15 g/l of agar, 10 g/l of 
tryptone, 5 g/l yeast extract and 5 g/l NaCl dissolved in 1000 ml of dH2O. LB medium 
was autoclaved at 121°C for 15 min. In some procedures, it was necessary to add a 
predetermined concentration of a specific antibiotic in the LB medium (Table 4). Once 
the media was cooled down it was aseptically poured into plastic Petri dishes in the 
laminar flow cabinet. 
3.1.5.3 SOC medium 
SOC culture medium was prepared by mixing 2 % of tryptone, 0,5 % of yeast extract, 
10 mM of NaCl and 2,5 mM of KCl. The medium was autoclaved at 121°C. Following 
the autoclavation 10 mM of MgCl2 and 20 mM of glucose were added.  
3.1.5.4 Liquid medium for DH10™ Bac cells 
Medium for DH10™ Bac cells were prepared by dissolving 2,5 ml of 10 mg/ml 
kanamycin, 0,5 ml of 7 mg/ml gentamicin, 5,0 ml of 1 mg/ml tetracycline, 0,835 ml of 
100 mM IPTG in 500 ml of LB liquid medium. 
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3.1.5.5 Solid medium for DH10™ Bac cells 
Solid medium was prepared by dissolving 2,5 ml of 10 mg/ml kanamycin, 5,0 ml of 1 
mg/ml tetracycline, 0,5 ml of 7 mg/ml gentamicin, 1,25 ml of 40 mg/ml X-gal and 
0,835 ml of 100 mM IPTG in 500 ml LB liquid medium. Medium was aseptically 
poured in Petri dishes.  
3.1.6 Chemicals 
Table 5: List of chemicals  
Preglednica 5: Seznam kemikalij  
Name of chemical  Producer Serial number 
40 % acrylamide and bis-acrylamide solution, 29:1 BIO-RAD 1610146 
Acidic acid  Carl Roth  6755,2 
Agarose Standard  Carl Roth  3810,3 
Albumin Fraktion V. proteasefrei  Carl Roth  T844.2 
Ammonium persulfate Sigma A3678 
Ethanol  Honeywell G3570 
Ethidium bromide Sigma E1510 
Glycerol AppliChem 7M011583 
Hydrochloric acid Sigma H1758 
Imidazole Sigma 56749-250G 
IPTG Sigma I6758 
Isopropanol Applichem A3928,1000 
Methanol  Sigma STBG1821V 
Natrium chloride Sigma S3014 
Natrium hydroxide  Sigma S8045 
Sodium chloride Carl Roth P029.2 
Sodium phosphate Sigma 342483-500G 
TRIS Sigma 84415 
3.1.7 Enzymes  
Table 6: List of enzymes  
Preglednica 6: Seznam encimov  
  
Name of enzyme Producer Serial number  
BamHI Roche  14317228 10 000 U (10 U/µl) 
HindIII Roche 14965221  
Lysozyme Sigma L6876  
NcoI Roche  19794321 1000 U (10 U/µl) 
NdeI Roche  13643822 1000 U (10 U/µl) 
RNase, DNase free Roche  12029800 500 ug/ml 
StuI Roche  13365123 2500 U (10 U/µl) 
T4 DNA Ligase Roche  14165157 500 U (1U/µl) 
XhoI Roche  13861225 5000 U (10 U/µl) 
Rustemi E. Antimicrobial potential of actinobacterial inhibitors of Mur ligases in bacterium C. difficile.  
  M.Sc. Thesis (Du2). Ljubljana, Univ. of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
 
30 
 
3.1.8 Antibiotics 
Table 7: List of antibiotics  
Preglednica 7: Seznam antibiotikov  
3.1.9 Buffers and reagents 
Table 8: List of reagents and buffers  
Preglednica 8: Seznam reagentov in pufrov  
Name Producer Serial number 
10x PBS  Carl Roth 9150,1 
10x TBS  BIO-RAD 1706435 
10x TGS Buffer BIO-RAD 1610732 
Anti-Mouse IgG Antibody QIAGEN 34660 
Cellfectin® II Reagent Invitrogen 10362-100 
cOmplete™, EDTA free Protease Inhibitor Cocktail SIGMA-ALDRICH® 56749-250G 
Coomassie Brilliant Blue R-250 BIO-RAD 1610436 
dH2O   
DNA Loading Dye (6X) Sigma O3756 
ligation buffer Roche  14028100 
MiliQ water   
Penta-His™ Antibody, BSA-free (100 μg) SIGMA-ALDRICH® A2304-1ML 
Phusion® High-Fidelity PCR Master Mix with HF Buffer New England BioLabs® M0531L 
Plus™ Reagent Invitrogen 11514-015 
Potassium acetate Sigma P1190 
Precision Plus Protein™ Dual Color Standards BIO-RAD 161-0374 
Roti®-CELL 10x PBS  Carl Roth 9150 
Roti®-Load 1    
Rotiphorese® 50x TAE Buffer Carl Roth  CL.86.2 
Sf-900™ II SFM (1X)  Gibco 10902-096 
SuperSignal™ West Dura Trial Kit Thermo Scientific 37071 
SuRE/Cut™ Buffer B Roche  13917300 
SuRE/Cut™ Buffer H Roche  11420700 
10x TBS  BIO-RAD 170-6435 
TEMED SIGMA-ALDRICH® 105K3720 
TGS buffer  BIO-RAD 170-6435 
  
Name of antibiotic Producer Serial number 
Ampicilin Sigma A0166 
Chloramphenicol Sigma C1919 
Gentamycin Sigma G1264 
Kanamycin  Fluka 60615 
Fosfomycin disodium salt Sigma P5396 
Tetracyclin  Sigma T7660 
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3.1.9.1 Buffers and regents used for SDS-page 
Buffers and regents used for SDS-page 
• Solution B  
Solution B was prepared with 90,9 g TRIS and 2 g of SDS dissolved in 500 ml of MiliQ 
water. HCl was added to obtain pH 8,8.  
• Solution C (pH 6,8) 
Solution C was prepared by mixing 30,3 g TRIS and 2 g of SDS dissolved in 500 ml of 
MiliQ water.  
• Running buffer 
SDS-page running buffer was prepared from stock solution of 10x TGS Buffer. The 
working concentration was prepared by mixing 100 ml of TGS with 900 ml of MiliQ 
water. 
• Composition of SDS-page gels  
All SDS-page gels for the protein analysis were prepared with 12 % separating gels. 
Table 9: Preparation of 12 % gels for SDS-page 
Preglednica 9: Priprava 12 % gelov za SDS-page 
5 % stacking gel 12 % separating gel 
1,26 ml dH2O 2,25 ml dH2O 
0,5 ml Solution C 1,25 ml Solution B 
0,24 ml 40 % acrylamide 1,25 ml 40 % acrylamide 
0,02 ml 10 % APS 
0,002 ml TEMED 
0,05 ml 10 % APS 
0,005 ml TEMED 
  
• 10 % APS (ammonium persulphate solution) 
10 % APS was prepared in a falcon tube with 5 g of ammonium persulphate per 50 ml 
of dH2O. Solution was stored at 4°C. 
• Destaining solution  
Destaining solution was prepared by mixing 500 ml of MiliQ, 400 ml of NaOH and 100 
ml of acidic acid. 
3.1.9.2 Buffers and reagents for Western blot 
• Transfer buffer (pH 8,3) 
10x Transfer buffer was prepared with 30,4 g of Tris, 144,2 g of Glycine, 10,0 g of SDS 
and MiliQ water to 1000 ml. Methanol was added additionaly (20 % methanol)  
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Working concentration of transfer buffer (1x) was prepared by adding 100 ml of 10x 
Transfer buffer, 200 ml of methanol and 700 ml of MiliQ water. 
• PBS solution 
Working concentration of PBS (1x) was prepared with 100 ml PBS (100x) and 900 ml 
MiliQ H2O. 
• TBS solution  
Working concentration of TBS (1x) was prepared with 100 ml TBS (100x) and 900 ml 
MiliQ H2O. 
• Solution for primary and secondary antibodies  
The antibody solution for detection of proteins on Western blot was prepared in 3 % of 
BSA by mixing 0,6 g of BSA dissolved in 20 ml of TBS. Primary antibody solution was 
prepared with Penta-His antibodies, BSA-free (100 μg), Mouse monoclonal IgG. 
Secondary antibodies were prepared in the same TBS antibody solution adding Anti-
mouse IgG antibodies. Buffers for protein purification 
• Binding buffer  
(Binding buffer was prepared in a volume of 500 ml by mixing 1,64 g of sodium 
phosphate, 14,6 g of NaCl and 0,68 g of imidazole. To balance pH 7,4 HCl was added. 
• Elution buffer  
Elution buffer was prepared in a volume of 500 ml by mixing 1,64 g of sodium 
phosphate, 14,6 g of NaCl and 17,02 g of imidazole. To balance pH 7,4 HCl was added.  
• Elution buffer Tris-HCl  
Tris-HCl buffer for size exclusion was prepared in a 1 l flask by dissolving 121,14 g of 
Tris in 800 ml of MiliQ water. 37 % HCl was added to balance pH 8,7. The solution 
was autoclaved. 
3.1.9.3 Buffers and reagents for the isolation of recombinant bacmid DNA 
• Solution I 
Solution I was prepared by adding 15 mM of Tris-HCl, 10 mM EDTA and 100 μg/ml 
RNase.  
• Solution II 
Solution II for isolation o recombinant bacmid DNA was prepared by mixing 0,2 M of 
NaOH and 1 % of SDS.  
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• TE buffer (pH 8,0) 
TE buffer was prepared by mixing 1 mM of Tris-HCl and 1 mM of EDTA. 
3.1.10 Kits and ladders 
Table 10: List of ladders and kits 
Preglednica 10: Seznam kitov in lestvic  
Name of the kit Producer 
E. coli MurA Assay Kit Plus-100 ProFoldin 
NucleoSpin® Gel and PCR Clean-up MACHEREY-NAGEL 
NucleoSpin® Plasmid MACHEREY-NAGEL 
PureYield™ Plasmid Maxiprep System  Promega  
S. aureus MurD Assay Kit Plus-100 ProFoldin 
Precision Plus Protein™ Dual Color Standards BIO-RAD 
1 Kb Plus DNA Ladder Carl Roth 
3.1.11 Laboratory equipment  
Table 11: List of laboratory equipment  
Preglednica 11: Seznam laboratorijske opreme  
Name  Producer 
AlphaImager® HP Gel Imaging System Alpha Innotec 
Amicon® Ultra - 4  Merck Millipore Ltd.  
arium® pro VF Ultrapure Water system  Sartorius 
Automatic pipettes Gilson 
Automatic pipettes RAININ 
Biophotometer Eppendorf 
Centrifuge 5427 R Eppendorf 
Combs BIO-RAD 
Digital Sonifier® BRANSON 
Gel Caster BIO-RAD 
Heaseus Incubator Kendro Laboratory Products 
HisTrap™ FF crude GE Healthcare Bio-Sciences AB 
ImageQuant LAS 500 CCD imager GE Healthcare Bio-Sciences AB 
Incubation Shaker Multitron Standard INFORS HAT 
Inoculation loops VWR 
Inverted fluorescence microscope Leica 
Microcentrifuge tubes TreffLab 
Microwave MIOSTAR 
Minicoldlab 2023 (AKTA purifier) LKB 
Mini-PROTEAN® Tetra Vertical Electrophoresis Cell BIO-RAD 
MULTIFUGE 1 S-R Heraseus 
NanoDrop™® Spectrophotometer ND-1000 witec ag 
NucleoCounter® chemometec 
PCR Workstation C.B.S Scientific  
pH meter METTLER TOLEDO  
Power supply Model 1000/500  BIO-RAD 
 (Continued) 
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(Continuation of Table 11)  
Name  Producer 
PowerPacTM Basic Power Supply BIO-RAD 
PROTEAN® combs BIO-RAD 
Rotary shaker Digene 
S@femate ECO Class 1.8 Microbiological Safety Cabinet EuroClone® 
Scale KERN 
Scale METTLER TOLEDO  
Serological pipettes (2, 5, 20, 50 ml) Corning®  
spatula  VWR 
Sub-Cell GT UV-Transparent Gel Tray BIO-RAD 
Sub-Cell® GT Cell BIO-RAD 
Superdex 200 10/300 GL column GE Healthcare Bio-Sciences AB 
Thermocycler: Labcycler Basic & Gradient SensoQuest GmbH 
Thermomixer comfort Eppendorf 
TPP® tissue culture 6 well plate Sigma 
TPP® tissue culture flask 25 Sigma 
TPP® tissue culture flask 75 Sigma 
Tubes (13 ml) SARSTEDT AG&Co. KG 
Tubes (15ml and 50 ml) Corning® CentriStar TM 
Vortex Genie 2 Bender & Hobein AG 
Water bath Heto Lab equipment  
Water bath TW 20 JULABO 
Wide Mini-Sub Cell GT Cell BIO-RAD 
3.1.12 Streptomyces sp. compounds used as inhibitors of C. difficile Mur ligases  
Compounds isolated from Streptomyces sp. were tested as potential inhibitors aginst 
MurA, MurB and MurC ligases. Isolated extracts were obtained from Christine 
Schorderet, BT 15, Bachelor ZHAW student. Streptomyces strains are from the ZHAW 
culture collection and were isolated at different habitats in Switzerland.  
Isolated extracts from Streptomyces used as potential inhibitors of Mur ligases:   
• Wurm_499_Strepto 
• Stup17_Strepto_A52 
• Opok_MB_A6 
• Opok_MB_B11 
• Opok_MB_C10 
Details of Streptomyces extracts are presented in ANNEX L.  
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3.2 METHODS 
3.2.1 Polymerase chain reaction (PCR) 
3.2.1.1 Template DNA preparation 
• Preparation of native C. difficile DNA 
The native DNA from eight different C. difficile strains was prepared as template DNA 
in a final working concentration by diluting 10 μl of DNA in 90 μl of dH2O for PCR.  
• Preparation of synthetic DNA 
The purchased samples of synthetic DNA were diluted in 100 μl of dH2O and 
centrifuged at maximum speed up to 1 minute. Samples were incubated for up to 10 min 
at 50°C and vortexed each minute during the incubation.  
3.2.1.2 PCR conditions and oligonucleotide primers  
All PCR reactions were performed in the same final volume (40 μl) and PCR 
programme (Table 13).  
• PCR mixture  
All PCR reactions were performed in 40 μl reaction mixtures with 2 μl of forward 
primer, 2 μl of reverse primer, 1 μl of template DNA sample, 20 μl of PCR Master Mix 
with HF Buffer and 15 μl of dH2O.  
• PCR programme  
Table 12: PCR programme 
Preglednica 13: PCR program 
Step Temp (ºC) Time (min) Cycle 
1 95 15:00 1 
2 94 0:30 10 
3 56 0:45 10 
4 72 01:00 10 
5 94 0:30 25 
6 56 0:45 25 
7 72 01:00 25 
8 72 07:00 1 
9 8 infinity 1 
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• Oligonucleotide primers list  
All primers for the work were ordered from Microsynth (The Swiss DNA Company).  
Table 13: List of oligonucleotide primers 
Preglednica 14: Seznam oligonukleotidnih začetnikov   
Type of DNA Primers Nucleotide sequence (5’→ 3’) 
 
P_f_HIS_EK_MurA_Bam
HI 
GCGCGCGGATCCATGCACCATCACCATGATGACGATGA
CAAGATGAGGAGATCAAAAAATATGGC  
 
P_f_EK_MurA_HindIII GCGCGCAAGCTTTTAATCTTCTACTATTTCCGATTTG 
NATIVE P_f_EK_MurA_NcoI 
GCGCGCCCATGGGGCATCACCATCACCATCACGATGAC
AAGATGAGGAGATCAAAAAATATGGC  
 P_r_MurA_EcoRI 
GCGGCGGCGGGATCTTTAATCTTCTACTATTTCGATTTG 
 
 
P_f_HIS_MurB_BamHI 
GCGCGCGGATCCATGCACCAATGACAGCTAAAGTTCAG
TATAATTTG 
 
P_r_MurB_HindIII GCGCGCAAGCTTTTAATCCTCTCCAAGTATTTTG 
 
P_f_MurAs_BamHI AAATTTGGATCCATGCGTCGTAGCAAAAACAT 
 
P_r_MurAs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGATCTTC
AACGATTTCAATCTGGCCA 
SYNTHETIC 
P_f_MurBs_BamHI AAATTTGGATCCATGACCGCAAAAGTGCAGTATA 
 
P_r_MurBs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGATCTTC
GCCCAGAATTTTAACCTCTTCT 
 
P_f_MurCs_BamHI AAATTTGGATCCATGAACATTCATTTTATTGGCAT 
 
P_r_MurCs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGTTTCTC
AACCAGCAGATCGGCAACTTTG 
 
3.2.2 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed on 1 % agarose in TAE buffer. Agarose gel 
was prepared with 2 g of agarose dissolved in 200 ml of 1 x TAE Buffer. The agarose 
mixture was microwaved until agarose were completely dissolved. The solution was 
cooled down and 0,7 μl/ml ethidium bromide was added. The agarose solution was 
poured to a gel caster and the comb was placed to create the slots. The gel was set for 
30-40 minutes at room temperature.  DNA samples were mixed with 5-8 μl of (6x) gel-
loading buffer, depending on the volume of the samples. The agarose gel was placed in 
the caster in the electrophoretic chamber and the samples and 1Kb Plus DNA Ladder 
were loaded. The gel electrophoresis was run for 30 minutes at the voltage of 120 V. 
The gel was directly placed in the UV Transilluminator to see orange bands of DNA 
under UV.  
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Agarose gel electrophoresis was performed to check and confirm each step of the 
cloning process.  
3.2.3 DNA fragment isolation from agarose gel  
The desired DNA fragments were sliced from the gel with a sterile scalpel and placed in 
a microcentrifuge tube. The isolation was performed using a commercial gel 
purification kit NucleoSpin® Gel and PCR Clean-up kit form Macherey-Nagel, 
following manufacturer’s instructions.  
3.2.4 Isolation of plasmid DNA – mini prep 
Plasmids pSIL and pET28 were isolated from E. coli Top10/NEB® and BL21 using 
NucleoSpin® Plasmid Kit from Macherey-Nagel, following manufacturer’s 
instructions. 
3.2.5 Isolation of plasmid DNA isolation – maxi prep  
Plasmid pET28 was purified using PureYield™ Plasmid Maxiprep System, following 
manufacturer’s instructions.  
After isolation of DNA fragments and plasmids their concentration was measured using 
Nanodrop. 
3.2.6 Digestion of plasmid DNA and PCR products  
• Restriction digestion of PCR products 
Isolated PCR products were digested with two appropriate restriction enzymes. 
Restriction mixture was carried out in a final volume of 20 μl, containing:  
10 μl of DNA  
l μl of each restriction endonucleases 
2 μl of 10x SuRE/Cut™ Buffer B or H (10-fold)  
6 μl of dH2O. 
The reaction was incubated at digestion temperature (usually 37°C) for 1 hour. The 
digested PCR products were confirmed using agarose gel electrophoresis.  
• Restriction digest of vector 
The isolated vectors pSIL and pET28 were digested with the appropriate restriction 
enzymes for cloning. To ensure that the used plasmid does not recircularize during 
ligation dephosphorylation was performed. Enzyme alkaline phosphatase was used to 
remove the 5’ phosphate group.  
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Isolated plasmid DNA was prepared for cloning with restriction digestion with two 
appropriate enzymes. Restriction mixture was carried out in a final volume of 100 μl: 
84 μl of plasmid DNA 
3 μl of each restriction endonucleases (10 U/μl) 
10 μl of 10x SuRE/Cut™ Buffer B or H  
The reaction was incubated at digestion temperature (usually 37°C) for 1 hour. 
Following the addition of 3 μl of alkaline phosphatase (CIAP) and incubated for 
additional 30 minutes at 37°C. The digested plasmids were confirmed with agarose gel 
electrophoresis. 
3.2.7 Ligation of the vector and insert  
Ligation was performed to fuse the insert to recipient plasmid. The recipient plasmid to 
insert ratio of 1:3 was used. Ligation mixture was performed in a final volume of 15 μl: 
1,5 μl of recipient plasmid 
11 μl of insert 
1,5 μl of 10 x T4 DNA ligase Buffer 
1,0 μl of T4 DNA ligase 
Volume of recipient plasmid and insert were calculated according to the measured 
concentration and the ratio.  
Negative controls (plasmid without insert) were set in parallel to check background 
colonies without an insert.  
3.2.8 Transformation 
After the ligation the next step was transformation of the DNA into bacteria. 
Transformation is one of the processes used by bacteria for the purpose of horizontal 
gene transferring. Transformation in a natural process, however many bacteria are 
unable to perform it and are therefore induced to develop competence. 
Antibiotic selection was applied in order to obain plasmids containing appropriate 
antibiotic resistance.  
3.2.8.1 Transformation in E. coli Top10/NEB® 10-beta competent cells 
NEB® 10-beta competent E. coli is a high efficiency derivate of DH10B for cloning 
large plasmids and preparation of high-quality plasmids. The transformation was 
performed according to manufacturer’s instructions. Competent cells were stored on -
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80°C and prior the use were thawed on ice. The whole volume of the ligation mixture 
was added directly into the vial of competent cells and mixed gently by tapping. The 
mixture was incubated on ice for 5 min, followed by incubation on 42°C for 30 seconds 
and immediately transferred on ice for 5 min. After the final incubation on ice, 250 μl of 
pre-warmed SOC medium was added to each vial. The vials were incubated on 37°C for 
exactly 1 hour at 225 rpm. The appropriate volumes (100 μl and 150 μl) transformation 
mixture was spread on two LB agar plates containing appropriate antibiotics: 
• LB medium supplemented with kanamycin (insert + pET28)  
• LB medium supplemented with ampicillin (insert + pSIL) 
Plates were incubated for 24 hours in the incubator at 37°C.  
3.2.8.2 Transformation in BL21 and BL21-CodonPlus (DE3) E. coli competent cells 
BL21 Competent E. coli is a widely used strain and is suitable for transformation and 
protein expression. The BL21-CodonPlus are most suitable for performing high-level 
protein expression. The BL21-CodonPlus strain naturally lack the Lon protease, which 
is responsible for degradation of recombinant proteins. Isolated plasmid pET28 with 
insert was transformed into BL21 or BL21-CodonPlus cells. 
The transformation was performed according to manufacturer’s instructions. Competent 
cells were stored on -80°C and prior the use was thawed on ice. After cells were 
thawed, 1,0 μl of DNA (plasmid + insert) was added directly into the vial of competent 
cells and mixed gently by tapping. The mixture was incubated on ice for 5 min, 
followed by incubation on 42°C for 10 seconds and immediately transferred on ice for 5 
min. After the final incubation on ice, 250 μl of pre-warmed SOC medium was added to 
each vial. The vials were incubated on 37°C for exactly 1 hour at 225 rpm. The 
appropriate volumes (100 μl and 150 μl) transformation mixture was spread on two LB 
agar plates containing appropriate antibiotic. LB plates were incubated overnight at 
37°C. 
3.2.8.3 Transformation in DH10Bac™ competent cells 
DH10Bac™ cells are in use as a host for production of recombinant bacmids.  Gene of 
interest (Mur ligases) was cloned into pFastBac™ Dual vector, which is controlled by 
two promoters (PH and p10).  
The transformation was performed according to manufacturer’s instructions. Competent 
cells were stored on -80°C and prior the use were thawed on ice. 1,0 μl of DNA (pSIL + 
MurX) was added directly into the vial of competent cells and mixed gently by tapping. 
The mixture was incubated on ice for 5 min, followed by incubation on 42°C for 45 
seconds and immediately transferred on ice for 2 min. After the final incubation on ice, 
250 μl of pre-warmed SOC medium was added to each vial. The vials were incubated 
on 37°C for exactly 4 hours at 225 rpm. The appropriate volumes (100 μl and 150 μl) 
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transformation mixture was spread on two LB agar plates containing appropriate 
antibiotics and selection markers: 50 μg/ml of kanamycin, 7 μg/ml of gentamicin, 10 
μg/ml of tetracycline, 100 μg/ml of X-gal, and 40 μg/ml of IPTG. Lb plates were 
incubated for 48 hours at 37°C. Recombinants were selected based on the blue-white 
screening. Colonies containing recombinant bacmid were white and were chosen for the 
analysis. 
3.2.9 Verification of clones using restriction digestion  
Following the transformation, the colonies from agar plates were used to inoculate the 
LB liquid media containing the appropriate antibiotics depending on the plasmid. The 
inoculated LB media was incubated overnight at 37°C with slightly shaking. Following 
the incubation, plasmids were isolated using NucleoSpin® Plasmid kit. The purified 
plasmids were digested using the same restriction endoucleases as for the initial step of 
cloning.  
The restriction mixture was the same for all reactions in the final volume of 20 μl, 
containing: 
4 μl plasmid DNA 
 
2 μl buffer B or H 
 
1 μl appropriate restriction endonucleases  
 
11 μl dH2O 
Restriction mixture was incubated in the incubator at 37°C for up to 30 min. Results of 
restriction digestion were verified using agarose gel electrophoresis.  
3.2.10 Expression of proteins 
Proteins in this research work were expressed in insect cells and E. coli.  
3.2.10.1 Protein expression in E. coli  
Preculture was prepared by inoculation of 10 ml of LB medium containing 
chloramphenicol and kanamycin with 1-2 μl of cells from glycerol stock and incubated 
overnight at 37°C in a shaking incubator at 250 rpm. After the incubation, culture for 
expression was prepared by inoculating 100 ml of LB medium containing 
chloramphenicol and kanamycin with 2 ml of overnight preculture. Cell suspension 
growth was monitored by measuring the optical density at 650 nm (OD650). When cell 
culture OD650 equalled around 0,6 induction with 100 μl of IPTG was performed and 
the culture was incubated at two different temperatures on 37°C or 20°C. During the 
four-hour incubation, samples of 1 ml were obtained every hour and after the overnight 
incubation. For each sample OD650 was measured and the appropriate volume of the 
culture was obtained to reach the OD650 1,8 of the sample. The samples were 
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centrifuged for 30s and the cell pellet was used for SDS-PAGE analysis. The cells from 
the overnight culture were harvest by centrifugation at 4500 x g for 10 minutes at 4°C. 
The supernatant was discarded, and the cells pellet were stored at -20°C and were used 
for the protein purification.  
3.2.10.2 Protein expression in Insect cells  
3.2.10.2.1 Isolation of bacmid DNA 
The LB media containing the appropriate antibiotics 50 µg/ml of kanamycin, 7 µg/ml of 
gentamicin and 10 µg/ml of tetracycline was inoculated with single white colonies 
chosen with blue and white screening method. The culture was incubated overnight on 
37°C. After the incubation, 1,5 ml of the culture was transferred to an Eppendorf tube 
and was centrifuged 14 000 x g for 1 minute. Supernatant was removed and 0,3 ml of 
Solution I was added to the cell pellet. After the pellet was resuspended by gently 
pipetting up and down 0,3 ml of Solution I was added and incubated 5 min at RT. 
Following the incubation, 0,3 ml of 3 M potassium acetate (pH 5,5) was added, gently 
mixed and incubated on ice for 5-10 min. After incubation mixture was centrifuged at 
14 000 x g for 10 min. Supernatant was transferred to Eppendorf tube containing 0,8 ml 
of isopropanol. The tubes were mixed by inverting them several times and placed on ice 
for 10 min. The tubes were centrifuged for 15 minutes at RT at 14 000 x g and 
supernatant was carefully removed. The pellet was washed by adding 0,5 ml of 70 % 
ethanol and the tubes were centrifuged at 14 000 x g for 5 minutes at RT. Supernatant 
was removed and the pellet was air dried for 5 – 10 minutes and dissolved in 40 µl of 
TE buffer (pH 8,0). Isolated bacmid DNA was stored at 4°C and used for the 
transfection of insect cells.  
3.2.10.2.2 Transfection of insect cells  
As the second expression host Sf-9 insect cells were used, which were grown in Sf-
900™ II SFM (1X) medium at 27°C with shaking.  
All the work for the transfection of insect cells was conducted in the laminar flow, to 
avoid contamination of the cells. To check the concentration of the cells, the 
concentration of insect cells was measured with NucleoCounter®. From the master 
stock of insect cells the sample of 1 ml was pipetted into the Eppendorf tube and 
aliquoted into the cassette and placed in NucleoCounter® instrument. The cell culture 
was diluted with fresh medium to reach the recommended density (106 cells per ml). 
The culture was separated by pipetting 2 ml of the cell culture into each well of the 6-
well-microwell plate. Transfection of insect cells is generally performed in adherent 
culture; therefore, the plate was incubated for 1 hour for the cells to attach to the 
bottom. For DNA samples two master mix of reagents were prepared. The first one was 
prepared by mixing the appropriate volume of Sf-900™ II SFM (1X) medium and 
Plus™ Reagent and incubated up to 10 minutes. The second master mix was prepared 
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by mixing Sf-900™ II SFM medium and CellFectin™ II reagent and incubated up to 30 
minutes. During the incubation the appropriate volume of DNA samples were 
transferred to sterile Eppendorf tubes to reach the concentration of 4 μg of DNA. After 
the incubation of reagents, the appropriate volume of the first master mix with the 
Plus™ Reagent was added to the bacmid DNA and incubated for 10 min. Next, the 
appropriate volume of the second master mix with CellFectin™ II reagent was added to 
the DNA samples and incubated for 30 min. The attachment of the cells was confirmed 
under the microscope and the DNA mixtures were spread in the wells. Plates were 
incubated for 5 to 7 days in the incubator on 27°C. In the following days the media of 
the cells was replaced with the fresh media, and the cells were observed under the 
microscope if the apoptosis of the cells have occurred. The state of transfection was 
monitored under the microscope for native DNA due to the RFP marker. After the 
incubation for 7 days the cells were harvested, and SDS-page and Western blot analysis 
were performed to confirm the synthesis of Mur ligases. The state of transfection with 
synthetic DNA was not monitored under the microscope due to lack of the marker. 
Therefore, SDS-page and Western blot analysis were performed on time course during 
the incubation process. After the incubation cells were harvested for protein 
purification.  
3.2.11 Protein purification 
3.2.11.1 Immobilized metal-affinity chromatography 
Immobilized metal-affinity chromatography (IMAC) is the most widely used technique 
for purification of overproduced recombinant proteins according to their affinity to 
specific metal ions. IMAC is based on the interaction between the metal ion Ni2+ 
immobilised on the matrix and amino acid histidine on the protein of interest. The 
strategy used in Ni-NTA was competitive elution with imidazole. Purification was 
conducted using ÄKTA protein purification system. For establishing the appropriate 
flow rate the UNICORN software was used. 
For the purification HisTrap FF Crude column was used. First the the column was 
washed with water to remove ethanol. Following the calibration of the column using 
binding buffer.  
Samples for purification were collected from the expression of proteins in E. coli and 
insect cells in a form of cell pellet. The cell pellet was dissolved in a binding buffer. 
Protease inhibitor and 0,5 ml of lysozyme was added and incubated for 30 minutes on 
ice. Following the sonication was performed in 5 cycles for 10 min. After the sonication 
the samples were centrifuged at 4700 x g for 10 minutes. The supernatant was loaded on 
the column in the volume of approximately 50 ml with syringe.  For the elution of the 
protein the appropriate programme (His superloop 50 ml) was used. Fractions for each 
step of purification were collected in the volume of 1 ml. The waste was also collected 
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to check if the protein was eluted in the waste. After the purification fractions with 
eluted protein were chosen for analysis based on the peaks of chromatogram. SDS-page 
and Western blot analaysis was performed for the purified proteins. AKTA system was 
washed at the same flow rate first with water and then with ethanol (20 %).  
3.2.11.2 Concentration of isolated proteins using Amicon® Centrifugal Filters 
Amicon® centrifugal tubes were used to concentrate and purify the fractions after 
purification step with IMAC. The sample was loaded into Amicon tube and centrifuged 
at 4500 rpm at 4°C to the final volume of 250-500 μl. For stoage purpose the final 
volume of the concentrated sample was storedin the microcentrifuge tube and its 
concentration was measured using Nanodrop.  
3.2.11.3 Size exclusion chromatography  
Size exclusion chromatography (SEC) was used as a second purification step to separate 
molecules based on differences in size as they pass through a SEC medium packed in a 
column. For the high-resolution fractionation AKTA purification system, UNICORN 
software and SuperdexTM 200 column were used. The buffer conditions were 100 mM 
Tris-HCl.  
Samples were first clarified by centrifugation in Amicon tubes, before application onto 
the column. This step was necessary to avoid the risk of blockage of the column. The 
system was prepared by washing the column with water at a flowrate 0,50 ml/min, to 
avoid overpressure. After the washing approximately 500 μl of purified protein was 
loaded to the column with the syringe. For the SEC the appropriate program was used 
(Gel filtration mit Superdex 200 Loop 500 μl) with flowrate 0,40 ml/min. Fractions for 
each step of purification were collected in the volume of 1 ml. After the purification 
fractions with eluted protein were chosen according to the peaks on chromatogram and 
analyzed with SDS-page and Western blot. 
3.2.12 Protein analysis  
3.2.12.1 SDS-page 
The SDS-page analysis in this research work was performed in 12 % SDS 
polyacrylamide separating gel covering the size range of 5-250 kDa. Polyacrylamide 
gels were prepared as following the instructions in the Table 9. The mix of solutions for 
separating gel was poured between two glass plates to polymerize and isopropanol was 
added on top of the gel to remove bubbles. After the gel was solidified isopropanol was 
removed and stacking gel was loaded all the way up to the top of the glass plates. Gel 
was casted with the comb generating the wells and the comb was afterwards carefully 
removed.  
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Samples obtained from different time courses of protein expression were prepared for 
SDS-page analysis. First the samples were centrifuged for 5min on 11 000 rpm to 
harvest the pellet. Supernatant was discarded and pellet was resuspended in 20 μl of 
Laemmli buffer Roti®-Load 1 (pH 6,6-7,2). The suspension was incubated for 5 min on 
95°C for denaturation.  
The casted gel was placed between two buffer chambers and equal amounts of protein 
samples 15 μl were loaded into the wells using a micropipette. The ladder  5 μl was 
loaded on the extreme right or left side into the well. The electrical path was run 
through the gel with the following conditions: 180 V, 45 min runtime in 1x TGS buffer.  
After the SDS-page was completed the gel was stained with Comassie Brilliant Blue on 
the shaking incubator for approximately 1 hour at room temperature. Following the 
destaining process with the destaining solution till we got clear visible bands. 
3.2.12.2 Western blot 
• Transferring the proteins from the gel to the membrane  
Polyacrylamide gels prepared in SDS-page electrophoresis were used to transfer the 
proteins from the gel to the membrane for Western blot analysis. The gel was placed in 
a 1x transfer buffer for 10 – 15 min. The transfer sandwich was assembled with no air 
bubbles trapped in between. The assembled sandwich was placed in the cassette and in 
the transfer tank with gel being on the anode and blot on the cathode. Ice block was 
added to the tank and blotting was done at 230 mA, 160 V for 1,5 h.  
• Incubation with antibody 
After the transfer the membrane was blocked with 3 % BSA in 20 ml of TBS at room 
temperature for 30 min. After the blocking, primary antibody solution against the target 
protein was added and incubated overnight on 4°C or for 1 h at RT. After the incubation 
the blot was washed 3 times for 5 min with PBS. The blot was incubated for 2 hours in 
the secondary antibody solution at RT. Washing step was performed again 3 times for 5 
min with PBS.  
• Imaging and data analysis 
A mix of 200 μl chemiluminescent substrate from the kit was applied to the blot. For 
capturing the chemiluminescent signals ImageQuant LAS 500 CCD camera-based 
imager was used. 
3.2.13 Activity assay and screening of inhibitors 
The E. coli MurA Assay is based on measurement of the inorganic phosphate generated 
from the MurA reaction. MurA enzyme transfers enolpyruvate from 
phosphoenolpyruvate (PEP) to uridine diphospho-N-acetylglucosamine (UNAG) 
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generating enolpyruvyl-UDPN-acetylglucosamine and inorganic phosphate. The 
released inorganic phosphate was measured by absorbance at 650 nm. The assay 
reactions and detection were performed in 96-well assay plates.  
The high throughput assay was used for screening inhibitors of E. coli MurA. The E. 
coli MurA Assay Kit Plus-100 was used to perform the assay. The kit contains the 
reagents for 100 assays including 400 μl of 10 x Assay buffer, 35 ul of 100 x PEP, 35 μl 
of 100 x UDO-N-acetylglucosamine (UGN), 35 μl of 100 x E. coli MurA (5000 nM) 
and 5 ml of dye MPA3000 for phosphate detection. The dye was used to 
spectrophotometrically measure the inorganic phosphate at 650 nm. The amount of 
released phosphate is proportional to the catalytic activity of the enzyme, it is important 
that the amount of released phosphate remains within the linear range of the phosphate 
calibration curve. If a compound inhibits the catalytic activity of the enzyme, less 
phosphate is released. The degree of inhibition of the enzyme is expressed by residual 
activity, which is the ratio between the activity of the enzyme in the presence of the test 
compound and the activity of the enzyme without the presence of the test compound.  
The reagent preparation and measurement of enzyme inhibitors was performed 
following the manufacturer’s instructions. The tested inhibitors had a different 
concentration range for Streptomyces extracts and for fosfomycin 5 mM concentration 
was used.  
3.2.13.1 Inhibitors and controls  
To determine the activity of MurA fosfomycin was used as inhibitor. Fosfomycin was 
prepared in the final inhibitory concentration of 5 mM in the total volume of 1 ml. 
Negative and positive controls were used to exclude the possibility of their impact on 
the activity of MurA. 
 Negative controls (NC) tested in assay:  
• methanol (MeOH)  
Methanol was tested due to extracts used as inhibitors were stored in it. The NC control 
was set using manufacturer’s instructions.  
• HCl  
HCl was tested to exclude the impact on MurA enzyme during the size exclusion as it 
was used in elution buffer. The NC control was set using manufacturer’s instructions. 
Positive control (PC) tested in the assay was MurA enzyme from E. coli which was 
included in the ordered kit. The PC control was set using manufacturer’s instructions.  
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4 RESULTS 
4.1 NATIVE DNA OF Clostridium difficile 
In this research work with native DNA of C. difficile MurA and MurB proteins were 
selected and analysed. MurD was used as a positive control.  
4.1.1 Expression of native MurA and MurB proteins in E. coli 
4.1.1.1 PCR 
The C. difficile mur genes were amplified from the C. difficile chromosome (strains 
CCOS-871 and CCOS-937) by PCR using appropriate primers (Supplementary Table 
14). PCR amplicons were confirmed using agarose gel electrophoresis and were 
purified from the gel with NucleoSpin® Gel and PCR Clean-up. All fragments were 
confirmed with DNA sequencing. 
 
Figure 10: PCR amplification of murA and murB from C. difficile strains (CCOS-871 and CCOS-937) 
1 kb molecular marker (Lane M); Lane 1: fragment murA from the strain CCOS-871; Lane 2: fragment 
murA from the strain CCOS-937; Lane 3: fragment murB from the strain CCOS-871; Lane 4: fragment 
murB from the strain CCOS-937. 
Slika 10: PCR pomnoževanje murA in murB genov iz dveh različnih sevov C. difficile 
1 kb molekulski standard marker (Linija M); Linija 1: fragment murA iz seva CCOS-871; Linija 2: 
fragment murA iz seva CCOS-937; Linija 3: fragment murB iz seva CCOS-871; Linija 4: fragment 
murB iz seva CCOS-937. 
4.1.1.2 Restriction digestion 
Restriction endonucleases are used to cut DNA at the specific recognition site forming 
blunt or sticky ends in the target DNA. For cloning the gene of interest into an 
expression vector, both must be cut with the appropriate enzymes to form compatible 
ends.  
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The resulting murA DNA fragments from PCR were cut with combination of different 
restriction enzymes. The digestion with different enzymes was performed with a 
purpose to find a combination of two enzymes which do not cut in murA. Figure 11 
show the results of restriction of murA with different combination of restriction 
enzymes and two different strains (details in the caption). Neither combination of 
endonucleases was successful, enzymes did not properly cut the right size of murA. For 
further analysis in this work murA from lane 1 (cut with NdeI and EcoRI from strain 
CD-871) was used. Two fragments on the agarose gel were cut out, purified using an 
appropriate kit and were ligated. After the ligation the correct size of murA was 
confirmed using the appropriate primers and multiplied by PCR (Table 14).  
 
Figure 11: Restriction digestion of murA with combination of different enzymes 
1 kb molecular marker (Lane M); Lane 1: fragment murA from the strain CD-871 cut with NdeI and 
EcoRI; Lane 2: fragment murA from the strain CCOS-871 cut with NcoI and HindIII; Lane 3 and 4: 
fragment murA from the strain CCOS-937 cut with NcoI and EcoRI; Lane 5 and 6: fragment murA from 
the strain CCOS-937 cut with NdeI and EcoRI. 
Slika 11: Rezultati encimske restrikcije murA s kombinacijo različnih encimov 
1 kb molekulski marker (Linija M); Linija 1: fragment murA iz seva CCOS-937 odrezan z NdeI in 
EcroRI; Linija 2: fragment murA iz seva CCOS-871 odrezan z NcoI in EcroRI; Liniji 3 in 4: fragment 
murA iz seva CCOS-937 odrezan z NcoI in EcoRI; Liniji 3 in 4: fragment murA iz seva CCOS-937 
odrezan z NdeI in EcoRI 
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Figure 12: Restriciton digestion of murB with NcoI and EcoRI 
1 kb molecular marker (Lane M); Lane 2: fragment murB from the strain CCOS-871 cut with NcoI and 
EcoRI 
Slika 12: Rezultati encimske restrikcije murB odrezan z NcoI in EcoRI 
1 kb molekulski marker (Linija M); Linija 2: fragment murB iz seva CCOS-871 odrezan z NcoI in EcroRI 
 
Figure 12 shows the results of digested murB with NcoI and EcoRI (lane 2). The 
digestion was successful in the second lane.  
 
Low-copy number plasmid pET28 used for cloning was digested using the same 
appropriate endonucleases as the DNA of insert. The digested products were extracted 
from agarose gel using NucleoSpin® Gel and PCR Clean-up kit.  
4.1.1.3 Verification of the plasmid containing an insert  
After the purification of digested plasmid and insert DNA ligation and transformation of 
ligated mixture was performed in Top10 E. coli competent cells. Verification of the 
insert in pET28 was performed. Purified plasmid DNA from recombinant clones was 
cleaved with the respective restriction enzymes and the insert was released. The size of 
the insert and plasmid was verified using gel electrophoresis.  
The results for MurA on Figure 13 show unsuccessful digestion of plasmid and insert. 
The insert was not released from the vector. Therefore, the insert in pET28 was 
confirmed with PCR using the appropriate primers. Negative control was performed to 
eliminate false positive results. For further analysis construct pET28::murA (lane 1) was 
used, which was previously confirmed with PCR.  Figure 14 show successful digestion 
of construct pET28::murB only in lane 1 the fragment was correspondent to the 
predicted size. Further analysis for murB were performed with the clone presented in 
lane 1.   
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Figure 13: Verification of constructs pET28:: murA with restriction digestion and PCR  
1 kb molecular weight marker (Lane M); (A) Lanes 1-8: pET28:: murA; (B) Lane 1: amplified murA; 
Lane 2: negative control  
Slika 13: Preverjanje konstruktov pET28:: murA z restrikcijo in PCR 
1 kb molekulski marker (Linija M); (A) Linije 1-8: pET28:: murA; (B) Linija1: pomnožen murA; Linija 
2: negativna kontrola  
 
 
Figure 14: Verification of constructs pET28::murB with restriction digestion  
1 kb molecular weight marker (Lane M); Lanes 1,2: digested murB and pET28 
Slika 14: Preverjanje konstruktov pET28::murB z restrikcijo in PCR 
1 kb molekulski marker (Linija M); Liniji 1,2: odrezan insert murB in plasmid pET28 
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4.1.1.4 Confirmation of positive clones following the transformation to BL21-
CodonPlus competent cells 
For over production of Mur ligases, plasmids with inserts pET28::murA, pET28::murB 
and pET28::murD (positive control) were transformed into E. coli BL21(DE3) 
competent cells. After transformation plasmid was purified and restriction digestion was 
carried out to determine if the plasmid contains the insert. The results of restriction 
digestion were unsuccessful and are not shown. The restriction digestion can be 
unsuccessful due to inactive enzyme, DNA methylation, the structure of substrate DNA, 
off target cleavage and gel-shift effect (Thermo Fisher).  
Therefore, the recombinant plasmid DNA was used directly in PCR mixture to check 
the positive clones. Figure 15 show the successful cloning of the insert in pET28 for 
both murA and murB genes. The size of the insert is correct, expect for murB the 
fragments in lanes 3-5 are slightly shifted up and were therefore not used for further 
expression and analysis. For further work clones murA (lane 1-A) and murB (lane 1-B) 
were chosen. 
 
 
Figure 15: Confirmation of positive clones with PCR 
1 kb molecular weight marker (Lane M); (A) Lanes 1-4: amplified murA; (B) Lanes 1-4: amplified murB  
Slika 15: Potrditev pozitivnih klonov s PCR pomnoževanjem  
1 kb molekulski marker (Linija M); (A) Linija 1-4: pomnožen murA; (B) Linije 1-4: pomnožen murB 
 
4.1.1.5 Expression of MurA, MurB and MurD proteins  
For the expression in E. coli BL21(DE3) the following recombinants were used: 
murA::pET28 (Fugure 15A; lane 1), murB::pET28 (Figure 15B; lane 1) and as positive 
control murD::pET28. Positive control was contributed by David Frasson, ZHAW, 
Departament of molecular biology. 
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Cultures containing recombinant plasmid with each insert were grown until the OD650 
0,6 at 37°C and induced using IPTG. For comparison of different growing conditions 
and to reach a maximum protein yield expression of the proteins was performed at 20°C 
and 37°C. Growth at high temperature (37°C) may lead to protein inactivation due to 
incomplete folding of the protein. Therefore, the solution was to lower the temperature 
of expression at 20°C (Rosano and Ceccarelli, 2014).  
Figure 16 shows the growth rate of bacterial culture during the expression of Mur 
proteins at different temperatures. After 1 hour of induction all bacterial culture for 
expression of correspondent Mur ligases show similar growth rate. As the incubation 
continued the differences in growth rate were more significant. E. coli culture 
expressing MurA shows a slight decline in growth rate at 37°C after induction with 
IPTG. In comparison no decline in growth rate of E. coli expressing MurA at 20 °C was 
shown. The growth rate for MurA was higher at 20°C, which confirms lower 
temperature is more convenient for expression of MurA. Growth rate of E. coli 
expressing MurB was lower than MurA. However, the growth was steady at both 
temperatures, with slight increase of growth after 3 h of incubation. Based on the 
obtained results the optimal temperature for expression of Mur ligases is 20°C. 
Therefore, for further investigation proteins during expression were incubated at 20°C. 
Positive control MurD had the highest growth rate at both temperatures during the 16 h 
expression time. MurD was synthetically ordered and codon optimized for the 
expression in insect cells and E. coli.  
 
Figure 16: Growth rate of E. coli BL21(DE) culture throughout the expression of MurA, MurB and MurD 
at 20°C and 37°C 
Slika 16: Rast bakterijske kulture E. coli BL21(DE3) med izražanjem MurA, MurB in MurD pri 20°C in 
37°C.   
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4.1.1.5.1 SDS-page and Western blot results 
SDS-page and Western blot analysis were carried out to determine the production of 
proteins MurA, MurB and positive control MurD.  
Figure 17 and 18 show unsuccessful expression of MurA and MurB, which were not 
overproduced as indicated by SDS-page and Western blot analysis. Under the same 
conditions MurD was significantly overproduced, which was used mainly to determine 
the proof of concept and to check the reagents. Figure 17 and 18 show results for the 
expression of Mur proteins at 20°C. Analysis were conducted also for expression at 
37°C and the results were the same, the protein expression was unsuccessful (data not 
shown).  
 
Figure 17: Results of SDS-page and Western blot analysis of recombinant MurA and MurD proteins 
expressed at 20°C 
(A) SDS-page of MurA and MurD (positive control) expression level in E. coli BL21(DE). (B) Western 
blot analysis of MurA and MurD expression level in E. coli BL21(DE). Lane L is Precision Plus 
Protein™ Dual Color Standards. The lanes indicated as 0 h represent expression profiles at the induction 
time point; lanes as 1 h, 2 h, 3 h and ON represent the expression level after induction with IPTG 
Slika 17: Rezultati SDS-page in Western blot analize rekombinantnih MurA in MurD pri 20°C 
(A) SDS-page prikaz izražanja MurA in MurD v E. coli BL21(DE). (B) Western blot prikaz izražanja 
MurA in MurD E. coli BL21(DE). Linija L je Precision Plus Protein™ Dual Color Standard. Linija 0 h 
predstavlja profil izražanja pred indukcijo. Linije 1 h, 2 h, 3 h in ON predstavljajo ekspresijo po indukciji 
z IPTG.  
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Figure 18: Results of SDS-page and Western blot analysis of recombinant MurB and MurD proteins 
expressed at 20°C 
(A) SDS-page of MurB and MurD (positive control) expression level in E. coli BL21(DE). (B) Western 
blot analysis of MurB and MurD expression level in E. coli BL21(DE). Lane L is Precision Plus 
Protein™ Dual Color Standards. The lanes indicated as 0 h represent expression profiles at the induction 
time point; lanes as 1 h, 2 h, 3 h and ON represent the expression level after induction with IPTG 
Slika 18:Rezultati SDS-page in Western blot analize rekombinantnih MurB in MurD proteinov pri 20°C 
(A) SDS-PAGE prikaz izražanja MurB in MurD v E. coli BL21(DE). (B) Western blot prikaz izražanja 
MurB in MurD E. coli BL21(DE). Linija L je Precision Plus Protein™ Dual Color Standard. Linija 0 h 
predstavlja profil izražanja pred indukcijo. Linije 1 h, 2 h, 3 h in ON predstavljajo ekspresijo po indukciji 
z IPTG.  
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4.1.2 Expression of native MurA and MurB in insect cells 
4.1.2.1 PCR  
The C. difficile mur genes were amplified from C. difficile chromosome using 
appropriate oligonucleotide primers (Table 14). For this purpose, Mur ligases were 
amplified from 8 different strains of C. difficile (Table 1).  
The results presented in Figure 16 show positive results for PCR reaction for murA 
gene except for strain CCOS-940 (Lane 5). The results of PCR for murB confirm the 
amplification of the murB gene except for strain CCOS -941.  
 
Figure 19: PCR amplicons of murA and murB from eight C. difficile strains 
1 kb molecular weight standard marker (Lane M); Lane 1: CCOS -871; Lane 2: CCOS -877; Lane 3: 
CCOS -937, Lane 4: CCOS -938, Lane 5: CCOS -940; Lane 6: CCOS -941; Lane 7: CCOS -957; Lane 8: 
CCOS -958. 
Slika 19: PCR amplikoni murA in murB genov iz osmih različnih sevov C. difficile 
1 kb molekulski standard marker (Linija M); Linija 1: CCOS -871; Linija 2: CCOS -877; Linija 3: CCOS 
-937, Linija 4: CCOS -938, Linija 5: CCOS-940; Linija 6: CCOS -941; Linija 7: CCOS -957; Linija 8: 
CCOS -958. 
The amplicons were purified from the gel using NucleoSpin® Gel and PCR Clean-up 
kit following the manufacturer’s instructions and their concentrations were measured 
with NanoDrop™. The samples were prepared and sent for sequencing in the total 
volume of 20 μl. Furthermore, the work was continued with murA (Lane 1: CCOS -
871) and murB (Lane 1: CCOS-871).  
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4.1.2.2 Restriction digestion  
The amplicons murA and murB were cut using restriction endonucleases BamHI and 
HindIII and cloned between the same sites of the high-copy number plasmid vector 
pSIL. The positive clones were confirmed by restriction digest and DNA sequencing.  
 
 
Figure 20: Results of restriction digest of murA (A) and murB (B) 
1 kb molecular weight marker (Lane M); (A) Lane 1 and 2: murA digested with BamHI and HindIII; (B) 
Lane 1 and 2: murB digested with HindIII and BamHI.  
Slika 20: Rezultati encimske restrikcije murA (A) in murB (B)  
1 kb molekulski marker (Linija M); (B) Liniji 1 in 2: murA odrezan z BamHI in HindIII; (B) Liniji 1 in 2: 
murB odrezan z HindIII in BamHI. 
 
4.1.2.3 Verification of the plasmid containing an insert 
Verification of the insert was performed after the ligation mixture was transformed in 
Top10 E. coli competent cells, verification of the insert was performed. Purified 
plasmid DNA from recombinant clones was cleaved with the respective restriction 
enzymes and the insert was released. The size of the insert and plasmid was verified on 
the gel electrophoresis.  
The result on Figure 21 and Figure 22 show successful ligation of plasmid and insert. 
The insert is released from the vector and the size is correct. For the murA only lane 7 
was correspondent to the predicted size of the insert. For murB the band from lanes 1 to 
8 were correspondent to the predicted size. Further analysis for murB were performed 
with the clone presented in lane 1.   
The inserts were sent for sequencing, because the PCR amplifying the gene from C. 
difficile might have introduced mutations.  
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Figure 21: Verification of transformants in pSIL:RFP and pSIL:GFP with restriction digestion of plasmid 
containing insert murA 
1 kb molecular weight marker (Lane M); Lanes 1-4: pSIL:GFP and murA; Lanes 5-6: pSIL:RFP with 
murA. Fragment marked with red was choosen for further analysis.   
Slika 21: Preverjanje transformant v pSIL:RFP in pSIL:GFP z restrikcijo plazmida z murA insertom 
1 kb molekulski marker (Linija M); Linije 1-4: pSIL:GFP in murA; Linije 5-6: pSIL:RFP in murA 
 
 
Figure 22: Verification of transformants in pSIL:RFP and pSIL:GFP using restriction digestion of 
plasmid containing insert murB 
1 kb molecular weight marker (Lane M); Lane 1-8: pSIL:GFP and murB; Lane 9-16: pSIL:GFP with 
murB. Fragment marked with red was choosen for further analysis. 
Slika 22: Preverjanje transformant v pSIL:RFP in pSIL:GFP z restrikcijo plazmida z murB insertom 
1 kb molekulski marker (Linija M); Linije 1-8: pSIL:GFP in murB; Linije 9-16: pSIL:RFP in murB 
 
4.1.2.4 Recombinant bacmid DNA isolation  
For expression in insect cells bacmid DNA is needed. Therefore, constructs 
pSIL_RFP::murA and pSIL_RFP::murB were transformed in DH10Bac™ competent 
cells. After the transformation, based on blue white screening white colonies from agar 
plated were used to inoculate the LB media with appropriate antibiotics. Isolation of 
bacmid DNA was carried out following the steps in Section 3.2.10.2.1. 
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The verification of the recombinants was performed using PCR amplification of murA 
and murB, using the appropriate primers in the Table 14. Figure 23 shows successful 
transposition of murA and murB into bacmid DNA.  
 
Figure 23: PCR amplicons of inserts murA and murB from isolated plasmid pFastBac 
1 kb molecular weight marker (Lane M); Lanes 1-4: murA; Lanes 5-8: murB  
Slika 23: PCR pomnoževanje inserta murA in murB iz izoliranega plazmida pFastBac 
1kb molekulski marker (Linija M); Linija 1-4: murA; Linije 5-8: murB 
 
The concentration of isolated bacmid DNA was measured with NanoDrop™. The 
following clones were used for the transfection of insect cells: MurA (Figure 23; lane 1 
and lane 3), MurB (Figure 23; lane 1 and 4). MurD was used as a positive control.  
Table 14: Concentrations of isolated bacmid DNA 
Preglednica 15: Koncentracije izolirane bakmidne DNK 
 
 
 
 
 
  
Bacmid DNA of MurX conc (ng/μl) 
A1 153 
A2 57,3 
A3 131,3 
A4 48,4 
B1 151,4 
B2 356,3 
B3 20,8 
B4 80,8 
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4.1.2.5 Observation of insect cells under fluorescent microscope  
Following transfection with bacmid DNA insect cells (Sf9 cell line) were observed 
under a fluorescent microscope. The plasmid pSIL had encoded a red fluorescence 
protein (RFP), which is a biological marker for detecting expression of proteins.  
Figure 24 indicate successful transfection with recombinant bacmid DNA and 
expression of observed proteins MurA, MurB and MurD under RFP marker. In figure 
24 (B) a slight difference in number of cells can be seen suggesting that virus infection 
could induce rapid lysis of insect cells (Roest et al., 2016).  
 
Figure 24: Observation of insect cells under fluorescence microscope 5 days post infection 
(A) Insect cells transfected using recombinant bacmid DNA containing RFP protein and murA; (B) Insect 
cells transfected with recombinant bacmid DNA containing RFP protein and murB (C); Positive control: 
Insect cells transfected with recombinant bacmid DNA containing RFP protein and murD  
Slika 24: Prikaz žuželčjih celic pod fluorescentim mikroskopom po 4 dneh transfekcije   
(A) žuželčje celice transfecirane z bakmidno DNA z zapisom za RFP in murA; (B) žuželčje celice 
transfecirane z bakmidno DNA z zapisom za RFP in murB; (C) Pozitivna kontrola: žuželčje celice 
transfecirane z bakmidno DNA z zapisom za RFP in murD. 
4.1.2.6 SDS-page and Western blot analysis 
SDS-page and Western blot analysis for cell lysate of insect cells used for the 
expression of MurA, B and D was performed after 7 days. The results are presented in 
the section 4.2.2.4, due to the comparison to synthetic DNA.  
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4.2 SYNTHETIC DNA OF Clostridium difficile 
Synthetic DNA of C. difficile murA, murB, murC genes was obtained from Thermo 
Fisher Scientific. The synthetic DNA was codon optimized for the expression in E. coli 
and insect cells. The genes were constructed from synthetic oligonucleotides and PCR. 
The murA fragment was inserted into pMA-T, while murB and murC fragments were 
inserted into pFastBac1.  
 
4.2.1 Expression of synthetic MurA, B and C proteins in E. coli 
4.2.1.1 Restriction digest  
For expression in E. coli Mur proteins were first cloned in pET28. Restriction digestion 
of murA from pMA-T, murB and murC from pFastBac1 with appropriate enzymes 
(BamHI and HindIII) was performed.  Plasmids pET28 and pSIL were also digested 
with the endonucleases BamHI and HindIII.  
 
Figure 25: Restriction digest of plasmids pMA-T and pFastBac1 obtaining the inserts  
Lane M: 1 kb molecular marker. Lane 1: digested pMA-T and murA. Lane 2: digested pFastBac and 
murB. Lane 3: digested pfastBac and murC. Lane 4 and 5: digested plasmid pET28 using HindIII and 
BamHI. Lane 7: digested plasmid pSIL using HindIII and BamHI. 
Slika 25: Encimska restrikcija pMA-T in pFastBac1 vektorjev z insertom  
Linija M: 1 kb molekulski marker Linija 1: murA in pMA-T po restrikciji. Linija 2: murB in pFastBac1 
po restrikciji. Linija 3: murC in pFastBac1 po restrikciji. Liniji 4 in 5: pET28 po restrikciji z HindIII in 
BamHI. Linija 7: pSIL odrezan z encimoma HindIII in BamHI.  
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4.2.1.2 Verification of the plasmid containing the insert 
After the digestion of inserts and plasmid pET28 ligation was carried out and the 
ligation mmixture was used for transformation of Top10 E. coli competent cells. Plates 
were incubated for up to 24 hours and grown colonies were used to inoculate LB media 
supplemented with kanamycin. Following the plasmid purification restriction digestion 
was performed using BamHI and HindIII to determine the correct size of the inserts. 
The results presented in Figure 26 on agarose gel confirm the correct size of the genes 
of interest.  
 
Figure 26: Verification of transformants in pET28 using restriction digestion of plasmid containing 
inserts murA, murB and murC 
Lane M: 1 kb molecular weight marker; Lanes 1-6: pET28 and murA. Lanes 7-12: pET28 and murB.  
Lanes 13-18: pET28 and murC  
Slika 26: Preverjanje transformant v pET28 z restrikcijo plazmida z murA, murB in murC inserti 
Lane M: 1 kb molekulski marker. Linija M: 1 kb molekulski marker Linije 1-6: murA in pET28. Linije 7-
12: murB in pET28. Linije 13-18: murC in pET28.  
 
4.2.1.3 Confirmation of positive clones after transformation to BL21-CodonPlus 
(DE3) competent cells 
Overproduction of MurA, MurB and MurC was performed using the BL21 E. coli 
strain. The confirmation of positive clones after transformation was performed using 
restriction digestion using appropriate restriction enzymes BamHI and HindIII.  
The correct size of the fragments on agarose gel was confirmed (Figure 24): for murA 
1284 bp, murB 996 bp and murC 1365 bp.  
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Figure 27: Confirmation of transformants in pET28a with restriction digestion of plasmid containing 
inserts murA, murB and murC 
Lane M: 1 kb molecular weight marker; Lanes 1-4: pET28 and murA. Lanes 5-8: pET28 and murB.  
Lanes 9-12: pET28 and murC  
Slika 27: Preverjanje transformant v pET28 z restrikcijo plazmida z murA, murB in murC inserti 
Lane M: 1 kb molekulski marker. Linija M: 1 kb molekulski marker Linije 1-4: murA in pET28. Linije 5-
8: murB in pET28. Linije 9-12: murC in pET28.  
Further analysis was conducted using the following clones: murA (lane 1), murB (lane 
5), murC (lane 9). Before expression the clones were confirmed with sequencing 
(Appendix G, H and I). 
4.2.1.4 Expression of MurA, MurB, MurC and MurD 
After confirming the correct size of the insert in pET28 plasmid isolated from E. coli 
BL21 (DE) host strain the protein expression was performed.  
Expression cultures were assembled by inoculating 100 ml of LB medium + kanamycin 
with the appropriate amount of isolated bacmid DNA. The E. coli culture was incubated 
with shaking at 37°C until the OD650 reached 0,6 and induced with 1 ml of IPTG. After 
induction the incubation was continued at 20°C to prevent the cell lysis and the 
formation of inclusion bodies.  
Figure 28 show the growth rates for expression cultures of E. coli BL21 (DE3). Growth 
rate was observed and the OD650 was measured at four different time courses during the 
incubation. Growth rate of all expression cultures was steady and similar. Furthermore, 
the significant increase in OD650 in the samples incubated overnight designate no cell 
lysis or toxicity of the expressed protein.   
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Figure 28: Growth rate of E. coli BL21(DE) culture throughout the expression of Mur ligases at 20°C 
Slika 28: Rast bakterijske kulture E. coli BL21(DE3) med izražanjem MurA, MurB, MurC in MurD 
proteinov pri 20°C  
 
4.2.1.4.1 SDS-page and Western blot analysis of MurA, B, C and MurD after protein 
expression 
SDS-page and Western blot analysis indicate protein expression of MurA, MurB and 
MurC. MurA, MurB, MurC and MurD proteins were significantly overproduced, as 
judged by the SDS-page and Western blot analysis and the corresponding size of the 
band. 
 
Figure 29: Results of SDS-page and Western blot analysis of MurA expressed in E. coli  
Lane L: Precision Plus Protein™ Dual Color Standard. (A): SDS-page analysis of MurA (48,0 kDa) 
expression. (B): Western blot analysis of MurA (48,0 kDa) expression. 
Slika 29: Rezultati SDS-page in Western blot analize MurA izražen v E. coli  
Linija L: marker, Precision Plus Protein™ Dual Color Standard. (A): SDS-page analiza ekspresije MurA 
(48,0 kDa). (B): Western blot analiza ekspresije MurA (48,0 kDa). 
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Figure 30: Results of SDS-page and Western blot analysis of MurB expressed in E. coli  
Lane L: Precision Plus Protein™ Dual Color Standard. A): SDS-page analysis of MurB (37,0 kDa) 
expression. (B): Western blot analysis of MurB (37,0 kDa) expression. 
Slika 30: Rezultati SDS-page in Western blot analize MurB izražen v E. coli  
Linija L: Precision Plus Protein™ Dual Color Standard. (A): SDS-page analiza ekspresije MurB (37,0 
kDa). (B): Western blot analiza ekspresije MurB (37,0 kDa). 
 
Figure 31: Results of SDS-Page and Western blot analysis of MurC expressed in E. coli  
Lane L: Precision Plus Protein™ Dual Color Standard. (A): SDS-page analysis of MurC (48,2 kDa) 
expression. (B): Western blot analysis of MuCc (48,2 kDa) expression. 
Slika 31: Rezultati SDS-page in Western blot analize MurC izražen v E. coli  
Linija L: Precision Plus Protein™ Dual Color Standard. (A): SDS-page analiza ekspresije MurC (48,2 
kDa). (B): Western blot analiza ekspresije MurC (48,2 kDa). 
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Figure 32: Results of SDS-page and Western blot analysis of MurD expressed in E. coli  
Lane L: Precision Plus Protein™ Dual Color Standard. Figure 32 (A): SDS-page analysis of MurD (49,5 
kDa) expression. Figure 32(B): Western blot analysis of MurD (49,5 kDa) expression. 
Slika 32: Rezultati SDS-page in Western blot analize MurD izražen v E. coli  
Linija L: Precision Plus Protein™ Dual Color Standard. Slika 32(A): SDS-page analiza ekspresije MurD 
(49,5 kDa). Slika 32(B): Western blot analiza ekspresije MurD (49,5 kDa). 
4.2.1.4.2 SDS-page and Western blot analysis of MurA and MurD after protein 
purification with IMAC 
MurA was chosen for further analysis in this research work. Protein purification was 
performed with IMAC following the detailed steps described in section 3.2.11. Cell 
pellet from the overnight protein expression was prepared for protein purification. The 
clear lysate was loaded on the column and purification was conducted. For SDS-PAGE 
and Western blot analysis fractions in the volume of 1 ml were used based on the 
chromatogram of the protein purification.  
 
Figure 33: Results of SDS-page (A) and Western blot (B) analysis of MurA after protein purification  
Lane L: Precision Plus Protein™ Dual Color Standard. cp– cell pellet of E. coli culture, sn - supernatant, 
ft - flow-through, 2-12 – eluted fractions 
Slika 33: Rezultati SDS-page (A) in Western blot (B) analize MurA po čiščenju proteina 
Linija L: Precision Plus Protein™ Dual Color Standard. Linije: cp- celični pelet, sn-supernatant, ft-flow-
through, 2-12 frakcije čiščenja proteina 
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Figure 34: Results of SDS-page (A) and Western blot (B) analysis of MurD after protein purification 
(positive control) 
Lane L: Precision Plus Protein™ Dual Color Standard. cp – cell pellet of E. coli culture, sn - supernatant, 
ft - flow-through, 3-10 – eluted fractions 
Slika 34: Rezultati SDS-page (A) in Western blot (B) analiza MurD po IMAC 
Linija L: Precision Plus Protein™ Dual Color Standard. Linije: cp - celični pelet, sn-supernatant, ft-flow-
through, 3-10 frakcije proteina 
 
Results after SDS-page analysis for MurA (figure 33) show higher amount of protein in 
fractions 4 to 9 and lower amount for fractions 9 to 11. For positive control MurD 
higher amount of protein was eluted in fractions 4 to 8 and lower in fractions 9 to 10. 
The results of SDS-page were confirmed using Western blot analysis with 
immunodetection antibodies. Further purification of proteins MurA and MurD using 
size exclusion was performed due to the presence of unspecific E. coli proteins in the 
elution’s steps.  
 
4.2.1.4.3 SDS-page and Western blot analysis of MurA and MurD after size exclusion 
chromatography  
Size exclusion chromatography was performed following protein purification with 
IMAC. The samples for SDS-page and Western blot were collected based on the 
fractions corresponding to the chromatogram.  
 
Figure 35: Results of SDS-page (A) and Western blot (B) analysis of MurA after size exclusion 
chromatography 
Lane L: Precision Plus Protein™ Dual Color Standard. Lanes: 7-22 – eluted fractions  
Slika 35: Rezultati SDS-page in Western blot analiza MurA po velikostni izločevalni kromatografiji 
Linija: Precision Plus Protein™ Dual Color Standard. Linije: 7-22 - frakcije proteina  
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Figure 36: Results of SDS-page (A) and Western blot (B) analysis of MurD after size exclusion 
chromatography  
Lane L: Precision Plus Protein™ Dual Color Standard. Lane: 7-22 - eluted fractions  
Slika 36: Rezultati SDS-page (A) in Western blot (B) analiza MurD po velikostni izločevalni 
kromatografiji 
Linija L: marker, Precision Plus Protein™ Dual Color Standard. Linije: 7-22 - frakcije proteina 
 
Results of SDS-page and Western blot analysis conducted after the second purification 
step with size exclusion confirm the expected size for both proteins MurA size 48.0 kDa 
and MurD 49,5 kDa.  
4.2.1.4.4 SDS-page and Western blot analysis of MurA and MurD after the 
concentration of the proteins with Amicon ® tubes 
In order to obtain a higher concentration of the purified proteins MurA and MurD the 
centrifugation of proteins in separate Amicon ® tubes was performed. The concentration 
was measured using NanoDrop™ and presented in the table below.  
Table 15: Protein concentrations after concentration in Amicon ® tubes 
Preglednica 16: Koncentracija proteinov po koncentriranju v Amicon ® tubi 
 
The presence and the correct size of the concentrated proteins was confirmed using 
SDS-page and Western blot analysis. Results shown in figure 37 confirm the positive 
results for MurA and MurD proteins with the corresponding sizes.  
Mur ligases Concentration (mg/ml) 
MurA 1,84 
MurD 1,96 
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Figure 37: Results of SDS-page (A) and Western blot (B) analysis of MurA and MurD after concentration 
in Amicon ® tube 
Lane L: Precision Plus Protein™ Dual Color Standard. Lane 1: MurA. Lane 2: MuD 
Slika 37: Rezultati SDS-page (A) in Western blot (B) analize MurA in MurD po koncentriranju v Amicon 
® tubi 
Linija L: Precision Plus Protein™ Dual Color Standard. Linja 1: MurA. Linija 2: MurD 
4.2.1.5 Inhibitory assay  
Inhibitory assay used in the research work was ProFoldin MurA Assay Kit Plus. 
Inhibitory assay was performed to determine the activity of MurA protein and to screen 
different extracts from different Streptomyces sp. species for a potential inhibitory effect 
on C. difficile MurA. As a positive control provided in the inhibitory assay was MurA 
ligase from E. coli.  
Extracts used in the inhibitory assay are presented in detail in the Annex K. The extracts 
were obtained from Christine Schorderet as the result from an ongoing Bachelor’s 
degree and were not completely defined.  
Enzyme activity of MurA was performed by measuring the production of ADP and 
inorganic phosphate generated from then enzyme reaction. The inorganic phosphate was 
measured by measuring the absorbance at 650 nm.  
Inhibitory assay was performed using a 96-well plate. The plate layout included the 
positive control MurA ligase form E. coli which was included in the kit and the purified 
recombinant MurA protein from C. difficile. The appropriate volume of inhibitors was 
added into the wells containing MurA ligase and the plate was incubated following the 
manufacturer’s instructions. Before the inhibitors were tested the activity test for the 
positive control and recombinant MurA was carried out in order to confirm the enzyme 
activity.  
The results presented in figures 38 and 39 for positive control MurA from E. coli and 
our overexpressed MurA from C. difficile show no inhibition of recombinant MurA 
from C. difficile and positive control MurA from E. coli. As a positive control for MurA 
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activity inhibitor fosfomycin was tested. However, in this inhibitory assay fosfomycin 
showed no inhibitory effect.  
 
Figure 38: Inhibitory effect of different inhibitors performed using recombinant MurA from C. difficile 
Slika 38: Inhibitorni vpliv različnih inhibitorjev proti MurA iz C. difficile  
 
 
Figure 39: Inhibitory effect of different inhibitors performed using MurA of E. coli included in ProFoldin 
Kit  
Slika 39: Inhibitorni vpliv različnih inhibitorjev proti MurA iz E. coli, ki je del ProFoldin kita    
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4.2.2 Expression of synthetic MurA, B, C and MurD in insect cells 
4.2.2.1 Cloning of MurA in pSIL  
The ordered construct of p-MA::murA needed to be modified for transformation in 
DH10  Bac™ competent cells. MurA was first cloned in pSIL. The construct for cloning 
was prepared using restriction digestion of insert and plasmid pSIL with restriction 
endonucleases BamHI and HindIII. After restriction digestion ligation was performed 
and transformation in DH10Bac™ competent cells was performed.  
The correct size of the murA clones was verified using restriction digestion with 
correspondent endonucleases BamHI and HindIII and agarose gel electrophoresis.  
 
Figure 40: Verification of the correct size of insert murA in pSIL 
Lane M:1 kb molecular weight standard.  
Slika 40: Potrditev prisotnosti inserta murA v plazmidu pSIL 
Linija M: lestvica, 1 kb molekularni standard  
 
4.2.2.2 Bacmid DNA isolation and verification of positive clones  
Synthetically provided constructs pFastBac:: murA, pFastBac:: murB and pFastBac:: 
murC were used for transformation in DH10 Bac™ competent cells. Following the 
transformation isolation of bacmid DNA was performed and purified from the culture 
following the steps decribed in Section 3.2.16. The concentration of isolated bacmid 
DNA was measured using Nanodrop and are presented in Table 16. 
Verification of the size of insert in bacmid DNA is correspondent to the correct size of 
Mur ligases PCR was performed using the primers in table 14. Results are presented in 
Figure 22 confirming the correct size of the inserts: murA (1284 bp), murB (966 bp) 
and murC (1365 bp).  
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Figure 41: Verification of murA, murB and murC inserts in pFastBacTM 
Lane M is 1kb standard marker; lanes 1 and 2: amplified murA; lanes 3 and 4 amplified murB; lanes 5 
and 6: amplified murC, lane 7: negative control  
Slika 41: Potrditev prisotnost murA, murB in murC insertov v pFastBac 
Linija M: 1kb standard marker; liniji 1 in 2: pomnožen murA; liniji 3 in 4: pomnožen murB; liniji 5 in 6: 
pomnožen murC; linija 7: negativna kontrola 
Table 16: Concentrations of isolated bacmid DNA 
Preglednica 17: Koncentracije izolirane bakmidne DNK 
mur genes Sample 1  
[ng/μl] 
Sample 2 
[ng/μl] 
Sample 3 
[ng/μl] 
Sample 4 
[ng/μl] 
murA 1072 864,5 1206,9 748,5 
murB 692,1 859,3 637,6 503,7 
murC 443,2 853,0 496,1                            758,9 
 
4.2.2.3 SDS-page and Western blot analysis of proteins expressed in insect cells 
For SDS-page and Western blot analysis the harvested cells from expression of proteins 
in insect cells were used. Mur A and B cloned from native C. difficile DNA was 
compared to MurA, B and C from C. difficile obtained and optimized synthetically. 
Figure 22 (A) shows successful expression of synthetically obtained C. difficile Mur 
ligases in comparison with native Mur ligases cloned from chromosomal DNA of C. 
difficile. The reason could be a repetitive DNA sequence within the insert causing DNA 
to fold on itself and become difficult or impossible to clone. Figure 42 (B) shows 
Western blot results only for MurD (positive control), since synthetically obtained Mur 
ligases were not ordered with an His-tag and were not immunodetectable. 
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Figure 42: Results of SDS-page and Western blot analysis of native MurA-C and synthetic MurA-C 
proteins expressed in insect cells 
Lane L: Precision Plus Protein™ Dual Color Standards; (A) Lane (1-6): SDS-page analysis of native Mur 
ligases; Lanes (7-12): synthetic Mur ligases expression level in insect cells; Lanee 13: MurD (positive 
control); Lane 14: negative control. (B) Lane L: Precision Plus Protein™ Dual Color Standards; Lane (1-
6): Western blot analysis of native Mur ligases; Lanes (7-12): synthetic Mur ligases expression level in 
insect cells; Lane 13: MurD (positive control); Lane 14: negative control. 
Slika 42: Rezultati SDS-page in Western blot analize ekspresije nativnih MurA-C in sintetičnih MurA-C 
proteinov v žuželčjih celicah 
Linija L je Precision Plus Protein™ Dual Color Standards; (A) SDS-page analiza nativnih Mur ligaz 
(linija 1-6) in sintetičnih Mur ligaz (linija 7-12); linija 13 je pozitivna kontrola (MurD); linija 14 je 
negativna kontrola. (B) Western blot analiza nativnih Mur ligaz (linija 1-6) in sintetičnih Mur ligaz (linija 
7-12); linija 13 je pozitivna kontrola (MurD); linija 14 je negativna kontrola. 
 
Further analysis with native and synthetic Mur ligases expressed in insect cells were not 
conducted due to the limited time course.  
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5 DISCUSSION  
Antibiotic resistance has become a major issue in recent years. The search for novel 
potential targets for the development of new antibiotics has increased to the big 
necessity. One of the main sources that present a potential antimicrobial target is 
biosynthesis of peptidoglycan. The biosynthesis pathway is catalyzed by Mur ligases 
which are the best target for development of novel inhibitors, due to their conserved 
structure. This research work is concentrated on Mur ligases of bacterium Clostridium. 
difficile. The emergence and spread of epidemic C. difficile strains is the result of the 
excessive use of antimicrobial agents and acquired resistance. C. difficile is resistant to a 
broad range of antibiotics such as erythromycin, chloramphenicol, vancomycin and 
tetracycline. The need for prevention of infections with C. difficile resistant strains is the 
first step in developing novel antimicrobial agents.  
The aim of this research work was production of recombinant Mur ligases from C. 
difficile and screening of different inhibitors against overproduced Mur ligases. 
Research work was carried out using modified synthetic DNA and native DNA from C. 
difficile. First molecular cloning of mur genes was performed using appropriate 
plasmids, following their expression in corresponding expression host. Recombinant 
proteins were analyzed using SDS-page and Western blot and then purified using 
IMAC. Activity of purified Mur ligases and screening of potential inhibitors was 
performed using inhibitory assay. Extracts isolated from Actinobacteria were tested as 
potential inhibitors against Mur ligases. Based on our observation and literature review 
we hypothesized to determine the antimicrobial potential of actinobacterial inhibitors 
against MurA and MurB ligases in Clostridium difficile.  Furthermore, we hypothesized 
the overproduction of active recombinant Mur enzyme obtained from native DNA and 
synthetic DNA and expressed in insect cells and E. coli.  
 
Molecular Cloning  
Mur ligases were cloned from native C. difficile DNA. Material for C. difficile native 
DNA was obtained from CCOS, Culture Collection of Switzerland. For this purpose, 
Mur ligases from different strains of C. difficile were tested using the appropriate 
restriction endonucleases.  Different C. difficile strains were used due to the insert being 
cut by different combination of restriction endonucleases. After testing different C. 
difficile strains research work was continued using strains CCOS-871 and CCOS-937. 
 
First separate digestion of the gene fragment amplified using PCR and plasmids pSIL 
and pET28a was performed. Plasmids for the cloning were chosen based on the 
expression host. In this step fragments with sticky ends were produced. Next, the 
digested gene fragment and the linearized plasmids were combined using the DNA 
ligase. Following the ligation, the recombinant plasmids were transformed in 
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corresponding competent cells. Plasmids were purified using purchased purifying kits 
and another restriction digestion was performed to verify if the insert is the right size 
and in the right orientation. Furthermore, optimized synthetic MurA, MurB and MurC 
ligases were purchased from Thermo Fisher for comparison to native Mur DNA. 
Synthetic Mur ligases were codon optimized in order to express in insect cells and E. 
coli.  
 
Results of molecular cloning for native MurA and MurB expressed in E. coli were 
analysed using restriction digestion or by PCR. During the verification of the clones by 
restriction digestion an issue with our insert being cut occurred. Despite testing different 
C. difficile strains and combination of restriction enzymes MurA was cut (shown on 
Figure 11). Therefore, two fragments were purified from the agarose gel and ligated. 
The correct size of the ligated MurA was afterwards verified using restriction digestion 
and PCR. Results are presented in Figure 13 showing unsuccessful restriction digestion 
of MurA and positive verification of MurA by PCR. The explanation to insert not being 
released from the vector could be due to enzyme activity being blocked by methylation 
of the template DNA. In some cases, the sequence similar to the one of the restriction 
endonucleases can be methylated and can overlap with the recognition sites of some 
enzymes and the methylated DNA cannot be cut. Furthermore, MurB was successfully 
digested from the cloning vector pET28. After transformation of constructs in BL21 
(DE2) competent cells the positive clones were confirmed using PCR and appropriate 
primers listed in Table 13.  
 
Native MurA and MurB were cloned also for expression in insect cells. Following the 
same cloning strategy and different cloning vector pSIL. Verification of positive 
recombinants was performed using restriction digestion and PCR. Results showed 
successful transposition of murA and murB to bacmid DNA.  
 
To compare the difference in cloning between native and synthetic DNA, the later was 
purchased and ordered as codon optimized for the expression in insect cells and E. coli. 
MurB and MurC were ordered in pFastBac and MurA in p-MA. Therefore, in order to 
express MurA in insect cells cloning in pSIL plasmid was conducted. In comparison to 
native DNA same cloning strategy was used for synthetically obtained DNA.MurA, 
MurB and MurC were first cloned for overproduction in E. coli. For that purpose, the 
constructs need to be cloned in pET28. Both expression vector and Mur ligases were 
successfully digested using restriction endonucleases BamHI and HindIII.  Therefore, 
using restriction digestion for cloning and verification of positive clones for synthetic 
DNA presented no issue in comparison to native DNA. The reason could be codon 
optimization of synthetic DNA for expression in E. coli and insect cells. Therefore, we 
concluded that molecular cloning using synthetic codon optimized DNA present no 
difficulties in comparison to native DNA. Research work was continued using clones 
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obtained from native and synthetic DNA for further comparison and investigation. 
Based on the verification of clones using PCR or restriction digestion and the 
concentration measured on Nanodrop positive cones were chosen for each Mur ligases 
for expression.  
 
The isolated plasmids were sequenced by external company and the sequences were 
analysed. The alignment of the sequences was performed using Blast. The checking of 
the DNA sequence was necessary due to the cases which can occur when the gene is 
inserted into a plasmid. Gene can go in backwards or the plasmid closes back up 
without a gene. The desired result was to obtain a recombinant plasmid where the gene 
of interest is inserted after the promoter, pointing in the forward direction.  
 
Two different expression hosts were used for the expression of recombinant proteins, 
BL21 E. coli and insect cells Sf9 from Spodoptera frugiperda. 
 
Expression of Mur ligases in E. coli  
Following the verification of the positive clones of MurA and MurB expression in E.  
coli culture was conducted. Overnight precultures of E. coli BL21 (DE3) harbouring 
either pET28a:: murA, pET28a:: murB or pET28:: murD were used to inoculate 100 ml 
LB medium supplemented with appropriate antibiotics. The bacterial cultures 
containing recombinant plasmids were incubated at 37°C with shaking until the optical 
density at 650 nm reached 0,6 and was induced by adding IPTG at a 100uM final 
concentration. When the optical density reached 0,6, two different expression 
temperatures were tested for each Mur ligases cloned from native C. difficile DNA. 
After induction with IPTG flasks with expression culture were incubated in parallel at 
20°C and 37°C. Cell growth was monitored OD650 measurement and samples were 
collected for SDS-page and Western blot analysis. Growth rates of E. coli BL21(DE3) 
culture are presented in Figure 16. Results show higher growth rate at 20°C which 
confirms 20°C being more optimal for expression of Mur ligases and was used for 
further expression of synthetic Mur ligase. Lower temperature also prevents inclusion 
body formation, which can result in incorrect or incomplete folding.  
 
Cells were harvested at the same time period during the expression of proteins and the 
cell pellet was used for SDS-page and Western blot. The results of SDS-page and 
Western blot analysis showed no protein expression of native MurA and MurB ligases 
at two different temperatures. Results are presented only for expression at 20°C in 
Figure 17 and Figure 18. Expression of positive control MurD was successful and was 
used as confirmation of the concept and reagents. MurD was also codon optimized in 
order to be expressed in insect cells and E. coli.  
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Synthetic MurA, MurB, MurC and MurD (positive control) ligases were expressed only 
at 20°C, as this temperature indicated higher growth rate for native Mur ligases. 
Expression was conducted following the same steps as for native DNA for comparison. 
Growth rate of bacterial culture during the expression presented in Figure 28 is higher 
for synthetic Mur ligases in comparison to native DNA. The results from SDS-page and 
Western blot analysis indicate expression of synthetic MurA, MurB, MurC and MurD 
ligases. The transformants synthesized an inducible protein of the expected size of C. 
difficile MurA 1284 bp, MurB 966 bp and MurC 1365 bp. 
 
There could be many reasons for unsuccessful expression of native MurA and MurB 
ligases. One of the reasons could be the right choice of the host cell, which initiates the 
outline of the whole process. For this purpose, different E. coli strains were tested. For 
further expression codon optimized BL21(DE3) E. coli was used for both native and 
synthetic DNA. BL21 strains are deficient in the Lon protease, which is responsible for 
degrading foreign proteins. Furthermore, due to the mutation in hsdSB plasmid loss is 
prevented. Expression of recombinant protein could present a metabolic burden on the 
microorganism, causing a decrease in generation time. Therefore, this could be the 
reason for a low growth rate of E. coli culture while expressing native MurA and MurB 
ligases. Furthermore, a high copy plasmid pET28a could also present a metabolic 
burden and decrease the bacterial growth rate. High copy plasmid may produce plasmid 
instability which leads to the reduction of the numbers of healthy organisms for protein 
synthesis. Another important reason of unsuccessful expression which could explain 
why the expression of native Mur ligases was successful is codon bias. Codon bias 
occurs when the number of synonymous codons in the foreign coding DNA differs from 
that of the host. There are multiple codons for several amino acids, resulting in many 
different coding sequences being possible for the same protein. Due to native DNA of 
C. difficile not being codon optimized for the expression in E. coli, at the moment of 
synthesis of the recombinant depletion of low abundance tRNAs can occur. This can 
lead to amino acid being incorporated at the wrong positions or truncation of the 
polypeptide, which affects the expression and activity of heterologous proteins 
(Gustafsson et al., 2004).  
 
In comparison expression of codon optimized Mur ligases in E. coli was successful, 
thus confirming codon bias could be the main reason for unsuccessful expression of 
native Mur ligases. Therefore, use of codon optimization of the foreign coding sequence 
was proven to be the right strategy for solving codon usage bias. The ordered synthetic 
DNA was optimized to modify the rare codons in the target gene to reflect the codon 
usage of the host (Menzella, 2011). 
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Expression of Mur ligases in insect cells 
Native Mur ligases were cloned in the recombinant donor plasmid pSIL and 
transformed in competent DH10 Bac E. coli cells. Transposition took place between 
donor plasmid and Bacmid resulting in recombinant bacmid. Next, extraction of 
recombinant bacmid DNA was performed based on the blue/white colony screening. 
Purification of white colonies of recombinant virus was conducted following the 
described protocol. Concentration of recombinant virus DNA was measured using 
Nanodrop. The measured concentrations are presented in Table 14 and the underlined 
measurements were used for transfection of insect cells. The Bacmid DNA 
concentration for transfection was 4 μg in 100 μl of CellFectin in 4 ml SF 900 II 
medium. Cell concentration was around 1x106 vc/ml in 20 ml of SF-900 II SFM 
medium in T175 flask. Transfected Sf-9 cells were incubated at 27°C for 7 days. 
Following the transfection of insect cells with Bacmid DNA the cells were incubated for 
approximately 7 days. MurA and MurB were cloned in pSIL containing RFP protein 
therefore expression was monitored under fluorescent microscope. Observation under 
microscope is presented in Figure 24. The observed images indicate successful 
transfection and expression of Mur ligases in Sf9 cell line. However, despite the cells 
observed under the fluorescent microscope indicated expression of the protein, SDS-
page and Western blot analysis showed no expression. Results are presented in Figure 
42  in comparison to synthetic DNA.  
 
Furthermore, codon optimized MurA, MurB, MurC and MurD were also expressed in 
insect cells. SDS-page indicate successful expression of MurA, MurB, MurC and 
MurD. The bands presented on SDS-page gel correspond to the correct expected size of 
C. difficile Mur ligases. Western-blot analysis indicate no protein expression, due to the 
lack of poly-histidine tags (His-tags) in the ordered optimized recombinant proteins. 
Proteins could not be detected using mouse anti-His monoclonal antibodies. Moreover, 
protein purification was also not performed for synthetic Mur ligases expressed in insect 
cells due to the absence of poly-histidine affinity tag for IMAC purification.  
 
Despite further analysis not being conducted for synthetic Mur ligases we can 
hypothesize that codon bias could be the main reason for unsuccessful expression of 
native Mur ligases in insect cells. Different organisms have different preferences of 
codons to encode specific amino acids. The reason for different codon preferences 
among different organisms is not entirely understood. However, some possible 
explanation for no expression could be: metabolic pressures, controlling gene 
expression through gene sequence, protein folding and adaptation to changing 
conditions. Another possible reason for unsuccessful expression of native Mur ligases 
could be cell lyisis of insect cells. Initial virus stock titre determination could be more 
or less than the typical titre of plaque forming units (pfu)/ml.  
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Due to the limited time course further investigation was not possible. Therefore, for 
purification step and further analysis only codon optimized MurA overexpressed in E. 
coli was used.  
 
Protein purification  
Bacterial cell pellet that produced the protein were lysed to release the target proteins 
MurA and MurD and affinity chromatography was used for the purification of proteins. 
The efficiency of the purification was analysed by biochemical methods SDS-page and 
Western blot. Recombinant MurA and MurD (positive control) were cloned in pET28a 
generating plasmids that encode proteins with 6xHistidine-tag at the C-terminal 
extremity. MurA was purified in native form by Ni-NTA (nikel-nitrilotracetic acid) 
chromatography using elution with an imidazole gradient following the manufacturer’s 
instructions. Purification was based on the interaction between a transition Ni2+ ion 
immobilized on a matrix and the histidine side chains. Composition of wash and elution 
buffer was modified to suit the particular application. All steps of purification were 
performed at 4°C. Fractions used for analysis on SDS-page and Western blot were 
collected based on the chromatogram peaks (results not shown). Based on the SDS-page 
and Western blot analysis the band of purified MurA and MurD proteins were of the 
expected size and significantly higher intensity as for other unspecific bands. Based on 
the literature IMAC is not classified as highly specific compared to the other affinity 
separation technologies. There are a couple of stress-responsive E. coli host proteins 
that have metal binding capacity, which can have an impact on the specificity of IMAC 
(Block et al., 2009). Therefore, this could be the explanation of the remaining of non-
target proteins in the mixture and the need for additional purification was required. To 
obtain a more homogenous protein size exclusion (SEC) was performed. Size exclusion 
helps to remove aggregates of high molecular weight by separating molecules by size. 
Results obtained from SDS-page and Western blot analysis indicate less copurified 
proteins in the fractions, but the fractions are not completely contaminants free. 
Moreover, we predicted the copurified proteins could interrupt the inhibitory activity at 
the final step of our research work. Following the two-step purification of MurA and 
MurD proteins, concentration and additional purification in the Amicon Ultra 
Centrifugal Filters was performed. A concentration factor of 30 x was used. The 
concentrated protein was finally confirmed by SDS-page and Western blot. To 
determine the final concentration Nanodrop measurement was conducted.  
 
Enzymatic activity of MurA ligase and potential inibitors  
MurA is an essential enzyme which catalyses the first step in the peptidoglycan 
synthesis in bacteria and has been an attractive target for antimicrobial drug discovery. 
The function of MurA is to transfer enolpyruvate from phosphoenolpyruvate (PEP) to 
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uridine diphospho-N-acetylglucosamine (UNAG) generating enolpyruvyl-UDPN-
acetylglucosamine (EP-UNAG) and inorganic phosphate.  
 
Final part of this research work was to obtain an active MurA enzyme and to screen 
potential inhibitors isolated from Streptomyces. The MurA activity was assayed by 
monitoring the production of inorganic phosphate using purchased E. coli MurA Assay 
Kit Plus-100 (ProFoldin). The same assay was used for screening of potential inhibitors. 
The purchased kit contained PEP, UDP-N-acetlyglucosamine (UGN), E. coli MurA 
which was used as a positive control and Dye for phosphate detection. Assay was 
carried out in a 96-wel assay plate for purified recombinant C. difficile MurA and for 
the positive control E. coli MurA following manufacturer’s instructions. The released 
inorganic phosphate was measured by absorbance at 650 nm. The measurements of 
inorganic phosphate for both MurA from C. difficile and positive control MurA from E. 
coli indicated a positive reaction and confirm that we expressed and purified a 
catalytically active MurA enzyme.  
 
Following the confirmation of the activity of MurA, screening of potential inhibitors 
was conducted. Assay was performed in the 96-well plate in parallel with MurA from 
C. difficile and MurA from E. coli provided in the purchased kit. Inhibitors isolated 
from Actinobateria used in the assay are listed in Annex K. As a positive control 
fosfomycin a well-known inhibitor of MurA ligases was used. Fosfomycin is known to 
inhibit MurA by binding to the cysteine in the active site of MurA ligases. Assay was 
conducted for both MurA using the same amount and order of potential inhibitors for 
better comparison. Data of the measurement of inorganic phosphate showed no 
inhibition of MurA from C. difficile and the MurA from E. coli. None of the tested 
inhibitors indicated a potential inhibition of MurA. However, despite fosfomycin being 
known and used as one of the inhibitors of MurA in this assay no inhibition activity was 
shown. One of the explanations could be the high emergence of new resistant and 
multiresistant strains of C. difficile including against first-line antibiotics (Isidro et al., 
2017). Moreover, only one concentration of fosfomycin was tested due to the limited 
time course. Therefore, different concentration range of fosfomycin should be tested 
dependent on the potency of the inhibitor to confirm the resistance of C. difficile. 
Similar explanation could be applied for potential inhibitors isolated from 
Actinobacteria. The isolates were not fully characterized and their concentration was not 
known. Therefore, we could not exclude their potential to inhibit MurA based only on 
one performed assay. Furthermore, some isolates were stored in methanol and 
fosfomycin was prepared in HCl which could have an impact on the inhibition activity. 
To examine the impact of HCl and methanol negative controls were set. The results 
show that both solutions used for preparation of inhibitors indicated an impact on the 
release of inorganic phosphate. All isolates stored in methanol had similar absorbance 
values, except for Wurm499.The latter was stored in water; therefore, the absorbance is 
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the highest due to water having no inhibitory effect. From all the obtained data of the 
inhibitory assay we can conclude that catalytically active MurA enzyme was 
overexpressed and purified. However, no potential inhibitor against MurA was detected. 
This could be due to the fact that inhibitors were not stored in the proper media to 
examine their inhibitory potential. For further investigations the storage media should 
be replaced with water or other solution which does not have an impact on the enzyme 
reaction. Further investigation should be conducted to fully characterize the isolates and 
to measure the correct inhibitory concentration which is necessary to examine the 
inhibitory potential of Streptomyces isolates. 
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6 CONCLUSION  
The results of our research work suggested different cloning efficiency between native 
and synthetic DNA. The cloning with native C. difficile DNA was not functional, which 
was confirmed by SDS-page and Western blot analysis. Some adjustments were made 
to clone and express Mur ligases from native DNA for example different C. difficile 
strains were tested, furthermore different expression conditions such as different 
expression hosts and temperature. However, troubleshooting of why expression of 
native Mur ligases was not successful should be conducted for more detailed report. 
Due to the limited time course the troubleshooting was not possible therefore the fastest 
approach by purchasing codon optimized MurA, MurB and MurC ligases was chosen 
and was proven to be successful. Expression of synthetically obtained Mur ligases was 
successful in both used expression systems E. coli and insect cells. 
Further analysis was conducted only for MurA ligases overexpressed in E. coli. 
Overexpressed MurA was purified and concentrated to increase the final protein 
concentration for the use in the inhibitory assay. Before the inhibitory assay was 
conducted obtained MurA was verified using SDS-page and Western blot.  
Activity assay confirmed successful overproduction of active MurA enzyme from C. 
difficile. Therefore, our aim to obtain an active recombinant protein was accomplished. 
The second aim to detect potential inhibitors against MurA ligase was not met. The use 
of Actinobacterial extracts as inhibitors have shown no inhibitory activity against C. 
difficile and E. coli MurA ligase. However, the tested Streptomyces extracts could 
potentially inhibit biosynthesis of peptidoglycan in the case of them being fully 
characterized, stored in the proper storage media and diluted to the right inhibitory 
concentrations. Nonetheless, to further investigate and analyze the inhibitory potential 
of Streptomyces isolates was not possible due to the limited time course.  
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7 SUMMARY (POVZETEK) 
7.1 SUMMARY  
Nowadays antibiotic resistance has become a major issue, due to the inappropriate use 
of antibiotics. Bacteria have developed genetic changes to survive the selective 
antibiotic pressure, leading to resistance against different antimicrobial agents. 
Therefore, in recent years a search for new antimicrobial agents and potential new 
targets has rapidly incresed. For this research work a major health care associated 
pathogen Clostridium difficile was chosen. C. difficile is a Gram positive, spore forming 
bacteria, which has become resistant to a wide range of antibiotics making it possible to 
colonize and infect despite antibiotics treatments. C. difficile infection (CDI) occurs 
when the gut microbiota is reduced after the antibiotic therapy. In search for new 
antimicrobials acting on new targets, peptidoglycan biosynthesis has been a main target. 
Moreover, the focus has shifted to the cytoplasmic steps of peptidoglycan biosynthesis, 
which is catalysed by Mur ligases (MurA to MurF). These enzymes present potential 
targets for the development of antimicrobial agents.  
Main aim of this thesis was overproduction of MurA, MurB and MurC ligases in two 
different expression systems, E. coli and insect cells. For this purpose, Mur ligases were 
cloned using appropriate plasmids from native C. difficile and synthetic codon 
optimized C. difficile DNA: Synthetic Mur ligases were ordered in order to examine the 
difference in cloning between codon optimized DNA and native DNA. Results 
indicated that cloning using codon optimized DNA presented no difficulties and was 
successful in comparison to native DNA: Research work was continued using only 
codon optimized MurA ligase overexpressed in E. coli, due to the limited time course. 
Results indicated overproduction of MurA on SDS-page gel with the corresponding 
size. Purification of the protein was performed using a two-step purification. First 
affinity chromatography was performed followed by size exclusion chromatography.  
After the confirmation of MurA protein enzymatic activity was examined using an 
inhibitory assay kit. Assay was carried out in a 96-well assay plate in parallel with a 
positive control from E. coli. The released inorganic phosphate from the reaction of 
MurA was measured and results confirmed that we overexpressed a catalytically active 
MurA enzme. The second part of the inhibitory assay was conducted to determine the 
potential inhibitory activity of extracts isolated from Streptomyces. Different extracts 
were tested in parallel against MurA from C. difficile and MurA from E. coli (positive 
control). Results indicated no inhibitory activity of the tested extracts. As positive 
control fosfomycin a well-known inhibitor against MurA was used. From all the 
obtained results we can conclude that overexpression and purification of MurA was 
successful. Tested extracts isolated from Streptomyces could present potential 
inhibitors, if they were fully characterized, stored in the proper media and the right 
inhibitory concentration.  
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7.2 POVZETEK 
Odpornost na antibiotike je v današnjem času prežeča težava do katere nas je pripeljala 
predvsem neustrezna uporaba le-teh. Bakterije razvijajo genetske spremembe z 
namenom, da bi preživele različne antimikrobne učinkovine in selektivni pritisk 
antibiotikov. Tako smo primorani vedno znova iskati nove antimikrobne učinkovine in 
potencialne tarče. Za raziskovalno delo smo izbrali mikroorganizem Clostridium 
difficile. Patogen, ki v zdravstvu povzroča ogromno preglavic. Gre za po Gramu 
pozitivno bakterijo, ki tvori spore. Med drugim ji slednje omogočajo obstanek v 
črevesnem ekosistemu kljub antibiotičnem zdravljenju pacienta. Okužba s C. difficle 
(ang. C. difficile infection, CDI) se najbolj pogosto pojavi ob porušenju mikrobiote v 
črevesju zaradi antibiotične terapije. Biointeza peptidoglikana predstavlja glavno tarčo 
za vpliv antimikrobnih učinkovin. Koraki biosinteze, ki potekajo v citoplazmi so 
katalizirani s strani Mur ligaz (od MurA do MurF), zato te encimi predstavljajo 
potencialne tarče za razvoj antimikrobnih učinkovin. 
V raziskovalni nalogi smo se osredotočali na produkcijo MurA, MurB in MurC ligaz. 
Uporabili smo dva sistema za izražanje - E. coli in celice insektov. Mur ligaze so bile 
klonirane z uporabo plazmidov iz divjega tipa C. difficle in optimizirane sintetične 
kodonske DNA. Slednje smo vključili z namenom, da bi opazovali razlike v kloniranju 
med nativno in optimizirano kodonsko DNA. Rezultati so pokazali, da je kloniranje z 
optimizirano kodonsko DNA manj zahtevno in bolj uspešno v primerjavi z nativno 
obliko. V nadaljevanju raziskovalnega dela smo se zato osredotočili le na tega in 
ekspresijo MurA ligaze v E. coli. Za preverjanje ekspresije MurA smo uporabili 
analitski metodi SDS-page in Western blot. Ustrezna velikost na gelu kot rezultat SDS-
page analize je pomenila pozitiven rezultat ekspresije MurA encima. Z dvostopenjskim 
čiščenjem smo encim nato izolirali ter analizirali z afinitetno kromatografijo, SDS-page 
in Western blot. Koncentracijo proteina smo pomerili s pomočjo Nanodrop inštrumenta.  
Po izolaciji encima je sledila potrditev aktivnosti le-tega. Uporabili smo inhibitorni kit 
za analizo. Izvajali smo jo v mikrotitrski plošči z 96 luknjami. Vključili smo vzporedno 
pozitivno kontrolo iz E. coli. Merili smo sproščen anoganski fosfat, ki se je sprostil ob 
reakciji z MurA. To nam je predstavljalo pozitiven rezultat in potrdili smo izražanje 
katalitično aktivnega MurA encima. V drugem delu pa smo potrjevali potencialno 
zaviralno aktivnost ekstraktov izoliranih iz rodu Streptomyces. Testirali smo različne 
ekstrakte v kombinaciji z MurA iz C. difficile in MurA iz E. coli (pozitivna kontrola). 
Nismo dokazali nobene inhibitorne aktivnosti testiranih ekstraktov. Kot pozitivno 
kontrolo smo vključili fosfomicin, ki je znan inhibitor MurA. Po obdelavi vseh 
rezultatov lahko zaključimo, da smo uspešno izrazili in izolirali MurA encim. Testirani 
ekstrakti iz streptomicet bi lahko predstavljali potencialne inhibitorje, če bi bili 
natančneje okarakterzirani, hranjeni v ustreznem mediju in uporabljeni pri ustrezni 
inhibitorni koncentraciji. Potrebni bi bili dodatni poskusi, izboljšave in ponovitev 
eksperimenta.  
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ANNEXES 
ANNEX A 
Synthetic codon optimized DNA sequence of murA gene. 
>18ABTJYP_2334589 
GAATTGGCGGAAGGCCGTCAAGGCCACGTGTCTTGTCCGCGGTACCGGATCCATGCGTCGTAGC
AAAAACATGGCAAAAATCATCGTGAAAAAAAGCAATCCGCTGAAAGGCAGCGTTAAAATTGATG
GTGCAAAAAATGCAGTGCTGCCGATTATTGCAGCAACCCTGCTGGCAAATGGTAAAAGCACCCT
GAATGGTGTTCCGAATCTGCGTGATGTTCATGTTATTAGCGATCTGCTGCGTCATGTTGGTGCA
GAAGTTGAATATAAAGAAAATACCCTGACCGTTGATGCCAGCAACATTAAAACCTGTGAAGCAC
CGTATGAACTGGTTCGTAAAATGCGTGCCAGCTTTCTGGTTATGGGTCCGCTGCTGGCACGTTT
TAATAGCACCAAAATTAGCATGCCTGGTGGTTGTGCAATTGGCACCCGTCCGATTGATCTGCAT
CTGAAAGGTTTTAAAGCACTGGGTGCCAAAATCGAAATGGATCATGGTTTTGTTGAAGCAGCAA
CCGAAAAACTGGTTGGCAATAAACTGTATCTGGATTTTCCGAGCGTTGGTGCCACCGAAAACAT
TATGATGGCAGCAAGCCTGGCAGAAGGCACCACCATTATTGAAAATGCAGCAGAAGAACCGGAA
ATTGTTGATCTGGCAAATTTTCTGAATGAGATGGGTGCAGATGTTAAAGGTGCAGGCACCAATA
CCATTAAAATCAAAGGTGTGAAAGAACTGAAAGGTGCCGAACATAATGTTATTCCGGATCGTAT
TGAAGCTGCCACCTATATGGTTGCAGCAGCAATGACCAAAGGTGATATTACCGTTGAAAATGTG
CTGATGGAACATCTGAAACCGGTTGTTGCAAAACTGCGTGAAGCAGGTTGTGAAATTACGGAAA
TGGATAATAGCGTTCGTGTTGTTGGTCCGAAAGTGCTGAAACCGATCGATATCAAAACCCTGCC
GCATCCGGGTTTTCCGACCGATGTTCAGGCACAGTTTATGGCAATGCTGACCGTGGCCAATGGC
ACCGGTGTTGTTATTGAAACCGTTTTTGAAAACCGCTTTATGCACGTGGCAGAATTTAATCGTA
TGGGTGCGAACATCAAAATCGATGGTCGTAGCGCAGTTGTTAATGGTGTTGATGAACTGCATGG
TGCAGCAGTTAATGCAACCGATCTGCGTGCCGGTGCAGCACTGATTCTGTGTGGTCTGATTGCA
GAAGGTGAAACCCAGATTGGTGAAATCTATCATATTCAGCGTGGCTATGTGGACATCGACAAAA
AAATCACCGCATTAGGTGGCCAGATTGAAATCGTTGAAGATTAAAAGCTTGAGCTCGGAGCACA
AGACTGGCCTCATGGGCCTTCCGCTCACTGC 
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ANNEX B 
Synthetic codon optimized DNA sequence of murB gene. 
>18ABTUVP_2335579 
AAATATTCCGGATTATTCATACCGTCCCACCATCGGGCGCGGATCCATGACCGCAAAAGTGCAG
TATAATCTTGGTGGCAATACCATGAACAACCAGGATATCTATATTAACCTGCTGAACATCCTGA
GCAAAGAGGATATTAAAGTTGACGAGCCGATGAAAAAACACATCAGCTTTCGTGTTGGTGGTCC
GGCAGATATTCTGGTTCGTCCGCGTACCGAAGAACAGCTGAAAAATGTTCTGAAACTGGTGAAA
GAAGAGAGCATTCCGTATCTGATTATTGGCAATGGTAGCAACATTCTGATTAAAGATGGTGGTA
TTCGTGGCGTTGTTATTGAACTGGCAGATAACTTTAACAGCTACGAGATTAATGATACCCGTAT
GACCGCACAGAGCGGTGCACTGCTGAGCGTTCTGGGTAAAGCACTGCAGAAACAAGAACTGAAA
GGTTTTGAATTTGCAAGCGGTATTCCGGGTACATTAGGTGGTGCACTGGCAATGAATGCCGGTG
CCTATGGTGGTGAAATGAAAGATATTGTTAAAAGCGTGCGCCTGATGGATATGGAAGGTAACAT
TTTTGAACTGAGCAACGAGCAGATGGAATTTGGTTATCGCAAAAGCATCATTAGCAAAAACGGT
TATATTGCCCTGAGCGCAGAACTGGAACTGCAAGAGGGTAATTATGATGAAATCAAGTCGCTGA
TGGATGATCTGGCAACCCGTCGTATTACCAAACAGCCGCTGAATTTTGCCAGCGCAGGTAGCAC
CTTTAAACGTCCGACCGGTTATTTTGCAGGTAAACTGATTGAAGAAACCGGTCTGCGTGGTCTG
ACCCTGCGTGGTGCACAGGTTAGCGAAAAACATTGTGGTTTTGTTGTGAATCAGGGTGAAGCAA
GCGCAAAAGACATTCTGGATCTGATCTATGTGATTAAGAGCGCAGTGTATGCGAAATTTGGTGT
TATGCTGGAAGAAGAGGTTAAAATTCTGGGCGAAGATTAAAAGCTTGTCGAGAAGTACTAGAGG
ATCATAATCAGCCATACCACA  
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ANNEX C 
Synthetic codon optimized DNA sequence of murC gene. 
>18ABTUUP_2335580 
AAATATTCCGGATTATTCATACCGTCCCACCATCGGGCGCGGATCCATGAACATTCATTTTATT
GGCATTGGTGGCATTAGCATGAGCGCACTGGCAGAAATTTGTATCAATAAAGGTTATCAGGTGA
GCGGCAGCGATAGCAATGAAAGCTATCTGCTGGATAAACTGCGTGATCAGGGTGCAACCATTTA
TATCGGTCAGAAAAAAGACAACATCAGCGACGATGTTAATATGGTTGTTTATACCGCAGCAGTG
CATCCGGATAATGAAGAACTGGTTGCAGCAAAAGAGAAGAACAAACTGGTTATGAATCGTGCAA
CCTTTCTGGGTCAGATTATGCGCGAATACAAAAATAGCATTGCAGTGAGCGGTACACATGGTAA
AACCAGCACCACCAGTATGCTGAGCACCATTTTTGAATATGCAGATCTGGACCCGACCATTCTG
GTTGGTGGTAATCTGAGCATGATTGGCGGTAATGTGAAAATTGGTAACAGCAACCACTTTATTA
CCGAAGCCTGTGAATATGTTGATAGCTTCCTGAACTTTAACCCGAAAATTAGCATTGTGCTGAA
CGTGGAAGAAGATCACCTGGATTATTTCAGCGGCATCGATGAAATTAAAGCCAGCTTTAACAAA
TTCGGCAAACTGCTGCCTCCGGAAGGCTATTTTATCATTAATGGTGATGATGAGAACATCGATG
ACATCCTGTATGATGTTAAAGCCACCATCATCAAATATGGTCGCGATAGCGATAATGATGCCGT
GATTAAAGATATCCACTTCGATAATAGCGGTCATGGCATTTTTCGCATTGAATATGAAGGTCGT
GATCTGGGTGAATTTGAACTGAGCGTTTATGGTCTGCACAACATTTATAACGCAAGCAGCGCAA
TTATGGCAGCACTGGTTAGCGGTATTGATCTGGAAACCATTCGCAAAAACATCAAAATCTATAA
AGGTGTGGGTCGTCGCTTTGAAACCAAAGGCTATTACAAAAATGCCCTGGTGGTTGATGATTAT
GCACATCATCCGACCGAACTGAAAGCAACCCTGGCAGCAGCAAAAAAACTGAAAAAAAGCACCC
TGTGGTGTATCTTTCAGCCGCATACCTATACACGTACCAAAAGCCTGCTGGGCGAATTTAGCGA
AGCATTTTATGCAGCCGATAAAGTGATTATCACCGATATTTATGCCGCACGTGAAAAAGATCCG
GGTGATATTCATAGCAAAGACCTGGTTGAAAAACTGTACCAGAATAACGTTGATGCCATCTACA
TCAAAGAGTTCGAGGACATCGTTAAATATCTGCGCGAAAACGTGAAAGATAACGATCTGGTTAT
TACCGCAGGCGCAGGTCCGATTTACAAAGTTGCCGATCTGCTGGTTGAGAAATAAAAGCTTGTC
GAGAAGTACTAGAGGATCATAATCAGCCATACCACA 
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ANNEX D 
Map of pET28a plasmid used for cloning in E. coli  
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ANNEX E 
Map of pET28a plasmid with murA insert 
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ANNEX F 
Map of pSIL plasmid with murA insert 
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ANNEX G 
Sequence of MurA of CCOS-871 aligned with used PCR primers 
The used PCR primers for MurA and MurB were based on the alignement with known 
sequences (CDS-CoDing Sequence), due to the sequence of CCOS-871 and CCOS-937 
being unknown.  
>38377930.seq - ID: MurA_871-MurA_f automatically edited with 
PhredPhrap, start with base no.: 14 Internal Params: Windowsize: 20, 
Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
GTAAAAAaGaGTAaTCCACTTAAaGGTAGTGTTAAAaTAGATGGTGCAAAAAATGCAGTTTTACCAATAA
TAGCAGCGACTTTATTAGCAAACGGAAAATCAACATTAAATGGAGTACCAAATTTAAGAGATGTTCATGT
TATATCAGATTTATTAAGACATGTAGGAGCAGAAGTTGAATATAAAGAAAATACACTTACTGTTGATGCA
AGCAATATAAAAACTTGTGAAGCTCCATATGAGCTTGTAAGAAAGATGAGAGCTTCTTTTTTGGTTATGG
GACCATTGCTTGCTAGATTTAATAGTACGAAAATTTCTATGCCAGGAGGATGTGCTATAGGAACAAGACC
TATAGATTTACATTTAAAAGGATTTAAAGCCTTAGGTGCAAAGATAGAAATGGACCATGGTTTTGTTGAA
GCAGCAACAGAAAAGTTAGTAGGAAATAAATTATATTTAGATTTCCCATCTGTTGGAGCAACTGAAAACA
TAATGATGGCAGCTTCTTTAGCAGAAGGGACTACAATAATAGAGAATGCAGCAGAAGAGCCAGAAATAGT
AGATTTAGCAAACTTCTTGAACGAAATGGGAGCAGATGTTAAAGGTGCAGGTACTAATACTATAAAAATA
AAAGGTGTTAAAGAGTTAAAAGGAGCAGAACATAATGTAATTCCAGACAGAATAGAAGCAGCAACTTATA
TGGTTGCAGCAGCTATGACAAAAGGTGATATAACTGTTGAAAATGTTTtAATGGAGCATTTAAAACCAGT
TGTAGCTAAATTAAGAGAAGCTGGTTGTGAAATAACAGAAATGGACAATTCTGTAAgAGTTGTAGGTCCA
AAnGTATTaAaaCCAATAGATATAAAAnCTTTACCACATCCAGGATTTCCTACAGATGTTCAAGCACAAT
TTATGGCTATGCTTACTGTAGCCAATGgaaCTggTGTAGTTATAGAAACTGTTTTtGAAAATAGattnaT
GCAtgTTGCTGAATTTAaTanAaTGGgTGCTAATAtAAAAaTAGATGGAagAAGTGCGgTTGTTAanggn
gTAgatnaacTAcacGgngCAGCAGTAAaCGCTA 
>38377932.seq - ID: MurA_871-MurA_r automatically edited with 
PhredPhrap, start with base no.: 11 Internal Params: Windowsize: 20, 
Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
gnGcTGTtatCTTCTTatCTATATcAacATAACCTCTTtGGATATGGTATATTTCTCCTATTTGAGTTTC
TCCTTCTGCTATAAGACCGCATAAAATAAGGGCTGCCCCTGCTCTTAAATCAGTAGCGTTTACTGCTGCA
CCGTGTAGCTCATCTACACCATTAACAACCGCACTTCTTCCATCTATTTTTATATTAGCACCCATTCTAT
TAAATTCAGCAACATGCATAAATCTATTTTCAAAAACAGTTTCTATAACTACACCAGTTCCATTGGCTAC
AGTAAGCATAGCCATAAATTGTGCTTGAACATCTGTAGGAAATCCTGGATGTGGTAAAGTTTTTATATCT
ATTGGTTTTAATACTTTTGGACCTACAACTCTTACAGAATTGTCCATTTCTGTTATTTCACAACCAGCTT
CTCTTAATTTAGCTACAACTGGTTTTAAATGCTCCATTAAAACATTTTCAACAGTTATATCACCTTTTGT
CATAGCTGCTGCAACCATATAAGTTGCTGCTTCTATTCTGTCTGGAATTACATTATGTTCTGCTCCTTTT
AACTCTTTAACACCTTTTATTTTTATAGTATTAGTACCTGCACCTTTAACATCTGCTCCCATTTCGTTCA
AGAAGTTTGCTAAATCTACTATTTCTGGCTCTTCTGCTGCATTCTCTATTATTGTAGTCCCTTCTGCTAA
AGAAGCTGCCATCATTATGTTTTCAGTTGCTCCAACAGATGGGAAATCTAAATATAATTTATTTCCTACT
AACTTTTCTGTTGCTGCTTCAACAAAACCATGGTCCATTTCTATCTTTGCACCTAAGGCTTTAAnTCCTT
TTAAATGTAAATCTATAGGTCTTGTTCCTATAGCACATCCTCCTGGCATagAAATTTTCGTACTATTAAA
TCTAGCAAGCAATGGTCCCATAACCAAAAAagAaGCTCTCATCTTTCTTACAAGCTCATATGGAGCTTCA
CAAGTTTTTATATTGCTTGCATCAACAGTAAGtGTATTTTCTTTataTTCAACTTCTGCTCCTACATGTC
TTAatAAaTCTGanaTAACATGAAcaTCTCTTAAaTTtGGtaCTCCATTTaaGGttgaTTTtCCgTTtGC
TAanAAaGTcncTGCTaTTATtggtAAAACTGCaTTTTTnGcaCcAT  
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ANNEX H 
Sequence of MurA of CCOS-937 aligned with used PCR primers 
>38377942.seq - ID: MurA_937-MurA_f automatically edited with 
PhredPhrap, start with base no.: 15 Internal Params: Windowsize: 
20, Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
GTAAAAAaGaGTAatCcACTTAAaGGTAGTGTTAAAATAGATGGTGCAAAAAATGCAGTTTTAC
CAATAATAGCAGCGACTTTATTAGCAAACGGGAAATCAACATTAAATGGAGTACCAAATTTAAG
AGATGTTCATGTTATATCAGATTTATTAAGACATGTAGGGGCAGAAGTTGAATATAAAGAAAAT
ACACTTACTGTTGATGCAAGCAATATAAAAACTTGTGAAGCTCCATATGAGCTTGTAAGAAAGA
TGAGAGCTTCTTTTTTGGTTATGGGGCCATTACTTGCTAGATTTAATAGTACGAAAATTTCTAT
GCCAGGAGGATGTGCTATAGGAACAAGACCTATAGATTTACATTTAAAAGGATTTAAAGCTTTA
GGTGCAAAAATAGAGATGGACCATGGTTTTGTTGAAGCAGCAACAGAAAAATTAGTAGGAAATA
AATTATATTTAGATTTTCCATCTGTTGGAGCAACTGAAAATATAATGATGGCAGCTTCTTTGGC
AGAAGGAACTACAATAAtagAAAATGCAGCagaagagCcAGAAATAGTAGATTTAGCAAACTTC
TTGAATGAAATgggaGcagaTGTTAAAGGAGCAGGTACTAATACTATAAAAatAAAaGgTGTTA
AanagctAAAanGgAGCagAACATAATGTAATtnccAAACAGAataaAanGCAGcnannttaTA
tgggtgCcAGCAGCCATGacAAAaaGGTgaataTAAcng 
 
>38377944.seq - ID: MurA_937-MurA_r automatically edited with 
PhredPhrap, start with base no.: 16 Internal Params: Windowsize: 
20, Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
GTtnTCTTCTTaTCTATATcAaCATAGCCTCTTtGGATATGGTATATTTCTCCTATTTGAGTTT
CTCCTTCTGCTATAAGACCACATAAAATAAGGGCTGCCCCTGCTCTTAAATCAGTAGCGTTTAC
TGCTGCACCATGTAGCTCATCTACACCATTAACAACCGCACTTCTTCCATCTATTTTTATATTA
GCACCCATTCTATTAAATTCAGCAACATGCATAAATCTATTTTCAAAAACAGTTTCTATAACTA
CACCAGTTCCATTAGCTACAGTAAGCATAGCCATAAATTGTGCTTGAACATCTGTAGGAAATCC
TGGATGTGGTAAAGTTTTTATATCTATTGGTTTTAATACCTTTGGACCTACAACTCTTACAGAA
TTGTCCATTTCTGTTATTTCACAACCAGCTTCTCTCAACTTAGCTACAACTGGTTTTAAATGCT
CCATTAAAACATTTTCAACAGTTATATCACCTTTTGTCATGGCTGCTGCAACCATATAAGTCGC
TGCTTCTATTCTGTCTGGAATTACATTATGTTCTGCTCCTTTTAGCTCTTTAACACCTTTTATT
TTTATAGTATTAGTACCTGCTCCTTTAACATCTGCTCCCATTTCATTCAAGAAGTTTGCTAAAT
CTACTATTTCTGGCTCTTCTGCTGCATTTTCTATTATTGTAGTTCCTTCTGCCAAAGAAGCTGC
CATCATTATATTTTCAGTTGCTCCAACAGATGGAAAATCTAAATATAATTTATTTCCTACTAAT
TTTTCTGTTGCTGCTTCAACAAAnCCATGGTCCATCTCTATTTTTGCACCTAAAGCTTTAAATC
CTTTTAAATGTAAATCTATAGGTCTTGTTCCTATAGCACATCCTCCTGGCATAGAAATTTTCGT
ACTATTAAnTCTAGCAAGTAATGGCCCCATAACCAAAAnnGAAGCTCTCATCTTTCTTACAAGC
TCATATGGAGCTTCACAAGTTTTtATATTGCttGCATCAACAGTAAGTGTATTTTCTttataTT
CAACTTCTGCCCcTACATGTCTTAAtAanTCTGaantAaCATGAACATCTCTTAAaTTTGGTaC
tCcATTtaaggttgATTtCCcGTTtGCTAatAAaGTcncTGCTATTATTGgnAAAnCTGCATTT
TTtgcaCcatcnnTTTtAaCcnTACCTTtaagGg 
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ANNEX I 
Sequence of MurB of CCOS-871 aligned with used PCR primers 
>38377958.seq - ID: MurB_871-MurB_f automatically edited with 
PhredPhrap, start with base no.: 31 Internal Params: Windowsize: 
20, Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
angAtATATATATAAaTTtATTAAATATATTAAGTAAAGAGGATATAAAAGTCGATGAACCTAT
GAAAAAACATATTTCATTTAGGGTAGGAGgaCCAGCAGATATATTAGTTAGACCTAGAACTGAA
GAACAATTAAAAAATGTACTTAAGTTGGTAAAAAAAGAATCTATTCCGTATTTAATAATTGGAA
ATGGTTCAAACATTTTAATTAAAGATGGTGGAATAAGAGGAGTGGTAATAGAATTAGCTGATAA
TTTCAATTCTTATGAGATAAATGATACTAGGATGACTGCTCAGTCAGGAGCTTTATTATCAGTT
TTAGGGAAAGCTCTCCAAAAGCAAGAATTAAAAGGGTTTGAGTTTGCATCAGGAATACCTGGCA
CATTGGGAGGAGCATTAGCCATGAATGCTGGAGCATATGGTGGTGAAATGAAGGACATAGTGAA
GTCAGTAAGACTGATGGATATGGAAGGCAATATATTTGAATTATCAAATGAACAGATGGAATTT
GGGTATAGAAAAAGTATAATATCGAAAAACGGATATATAGCTTTATCAGCAGAATTAGAGTTAC
AAGAAGGAAATTATGATGAAATAAAAAGTTTAATGGATGATTTAGCGACGAGAAGAATAACTAA
ACAGCCATTAAATTTTGCTAGTGCAGGAAGTACATTTAAGAGACCAACAGGATATTTtGCAGGT
AAATTAATAGAAGAAACTGGATTGAGAGGTCTTACTTTAAGAGGAGCACAAGTATCTGagAAGC
ATTGTGGATTTGTAGTCAATCAAGGAGAAGCAAGTGCTAAAGATATTTTGGATTTAATATATGT
TAtAAAaaGTGCTGTATATGCCAAGTTTGGGgTTATGTTGGAAGAAGAAGTCAAAATACTTGGA
GAGGATTAAAGCCTTGCGcGcaa 
 
>38377960.seq - ID: MurB_871-MurB_r automatically edited with 
PhredPhrap, start with base no.: 17 Internal Params: Windowsize: 
20, Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
TAaCCcnAAnCTTGgcATaTACAGCACTTTTtATAACATATATTAAATCCAAAATATCTTTAGC
ACTTGCTTCTCCTTGATTGACTACAAATCCACAATGCTTCTCAGATACTTGTGCTCCTCTTAAA
GTAAGACCTCTCAATCCAGTTTCTTCTATTAATTTACCTGCAAAATATCCTGTTGGTCTCTTAA
ATGTACTTCCTGCACTAGCAAAATTTAATGGCTGTTTAGTTATTCTTCTCGTCGCTAAATCATC
CATTAAACTTTTTATTTCATCATAATTTCCTTCTTGTAACTCTAATTCTGCTGATAAAGCTATA
TATCCGTTTTTCGATATTATACTTTTTCTATACCCAAATTCCATCTGTTCATTTGATAATTCAA
ATATATTGCCTTCCATATCCATCAGTCTTACTGACTTCACTATGTCCTTCATTTCACCACCATA
TGCTCCAGCATTCATGGCTAATGCTCCTCCCAATGTGCCAGGTATTCCTGATGCAAACTCAAAC
CCTTTTAATTCTTGCTTTTGGAGAGCTTTCCCTAAAACTGATAATAAAGCTCCTGACTGAGCAG
TCATCCTAGTATCATTTATCTCATAAGAATTGAAATTATCAGCTAATTCTATTACCACTCCTCT
TATTCCACCATCTTTAATTAAAATGTTTGAACCATTTCCAATTATTAAATACGGAATAGATTCT
TTTTTTACCAACTTAAGTACATTTTTTAATTGTTCTTCAGTTCTAGGTCTAACTAATATATCTG
CTGGTCCTCCTACCCTAAATGAAATATGTTTTTTCATAGGTTCATCGACTTTTATATCCTCTTT
ACTTAATATATTTAATAAATTTATATATATATCTTGATTATTCATTGTATTTCCTCCCAAATTA
TACTGAACTTTAGCTGTCATTGGTGATGGTGATGGTGCaTGaatncccngcgcaa 
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ANNEX J 
Sequence of MurB of CCOS-937 aligned with used PCR primers 
>38377970.seq - ID: MurB_937-MurB_f automatically edited with 
PhredPhrap, start with base no.: 14 Internal Params: Windowsize: 
20, Goodqual: 19, Badqual: 10, Minseqlength: 50, nbadelimit: 1 
caaTGAaTAaTCAagaTatATATATAAaTTtATTAAaTATATTAAGTAAAGAGgatATAAAAGT
CGATGAACCTATGAAAAAACATATTTCATTTAGGGTAGGAGgaCCAGCAGATATATTAGTTAGA
CCTAGAACAGAAGAACAATTAAAAAATGTACTTAAGTTGGTAAAAAAAGAATCTATTCCGTATT
TAATAATTGGAAATGGTTCAAACATTTTAATTAAAGATGGTGGAATAAGAGGAGTGGTAATAGA
ATTAGCTGATAATTTTAACTCTTATGAGATAAATGATACTAGGATGACTGCTCAGTCAGGAGCT
TTATTATCAGTTTTAGGTAAAGCTCTCCAAAAGCAAGAATTAAAAGGGTTTGAGTTTGCATCAG
GAATACCTGGGACATTGGGAGGAGCATTAGCCATGAATGCTGGAGCATATGGTGGTGAAATGAA
GGACATAGTAAAGTCAGTAAGAGTGATGGATATGGAAGGCAATATATTTGAATTGTCAAATAAA
CAGATGGAATTTGGGTATAGAAAAAGTATAATATCGAAAAATGGATATATAGCTTTATCAGCAG
AATTAGAATTACAAGAAGGCAATTATGATGAAATAAAAAGTTTAATGGATGATTTAGCGACGAG
AAGAATAACTAAACAGCCATTAAATTTTGCTAGTGCAGGAAGTACATTTAAGAGACCAACAGGA
TATTTTGCAGGTAAATTAATAGAAGAAACTGGATTGAGAGGTCTTACTTTAAGAGGAGCACAAG
TGTCTGAGAAGCATTGTGGATTTGTAGTAAATCAAGGAGAAGCAAGTGCTAAAGATATTTTGGA
TTTAATATATGTTATAAAAaGTGCTGTATATGCCAAGTTTGGGgTTATGTTGGAAGAAGAAGTC
AAAATACTTGGAGAGGattAAaGCctttgCGCGCAa 
 
>38377972.seq - ID: MurB_937-MurB_r on 2018/3/6-19:19:15 
automatically edited with PhredPhrap, start with base no.: 23 
Internal Params: Windowsize: 20, Goodqual: 19, Badqual: 10, 
Minseqlength: 50, nbadelimit: 1 
CCcnAAnCTTGGCATaTACAGCACTTTTTATAACATATATTAAATCCAAAATATCTTTAGCACT
TGCTTCTCCTTGATTTACTACAAATCCACAATGCTTCTCAGACACTTGTGCTCCTCTTAAAGTA
AGACCTCTCAATCCAGTTTCTTCTATTAATTTACCTGCAAAATATCCTGTTGGTCTCTTAAATG
TACTTCCTGCACTAGCAAAATTTAATGGCTGTTTAGTTATTCTTCTCGTCGCTAAATCATCCAT
TAAACTTTTTATTTCATCATAATTGCCTTCTTGTAATTCTAATTCTGCTGATAAAGCTATATAT
CCATTTTTCGATATTATACTTTTTCTATACCCAAATTCCATCTGTTTATTTGACAATTCAAATA
TATTGCCTTCCATATCCATCACTCTTACTGACTTTACTATGTCCTTCATTTCACCACCATATGC
TCCAGCATTCATGGCTAATGCTCCTCCCAATGTCCCAGGTATTCCTGATGCAAACTCAAACCCT
TTTAATTCTTGCTTTTGGAGAGCTTTACCTAAAACTGATAATAAAGCTCCTGACTGAGCAGTCA
TCCTAGTATCATTTATCTCATAAGAGTTAAAATTATCAGCTAATTCTATTACCACTCCTCTTAT
TCCACCATCTTTAATTAAAATGTTTGAACCATTTCCAATTATTAAATACGGAATagaTTCTTTT
TTTACCAACTTAAGTACATTTTTTAATTGTTCTTCTGTTCTAGGTCTAACTAATATATCTGCTG
GTCCTCCTACCCTAAATGAAATATGTTTTTTCATAGGTTCATCGACTTTTATATCCTCTTTACT
TAATATATTTAATAAnTTTATATATATATCTTGATTATTCATTGTATTTCCTCCCAAATTATAC
TGAACTTTAGCTGTCATTGGTGATGGTGATGGTGCATggatccccntcgcA 
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ANNEX K 
Extracts isolated from Streptomyces used as inhibitors of Mur ligases 
Code Original Code 16S rDNA Phylogenetic Remarks Extract 
Wurm_499_Strept
o 
Wurm_-
4_HV_12.1.1_Strepto_
V 
Streptomyces 
europaeiscabiei 
99 % 
Streptomyces 
scabiei 99 % 
Streptomyces 
deccanensis 99 % 
Streptomyces 
neyagawaensis         
99 % 
Bacteria; 
Actinobacteria; 
Streptomycetales; 
Streptomycetacea
e; 
            
Streptomyces 
Sometimes 
inhibition 
of E. coli 
and 
S.aureus 
concentrated 
Medium 
Gym4 
(Streptomyce
s grow in 
this 
medium)  
    
Stup17_Strepto_A
52 
Stup17_A_-
3_MPA_3.1.1_III 
Streptomyces 
gardneri 99 % 
Streptomyces 
narbonensis 99 % 
Streptomyces 
lateritius 99 % 
Streptomyces 
zaomyceticus 99 
% 
 Bacteria; 
Actinobacteria; 
Streptomycetales; 
Streptomycetacea
e; 
            
Streptomyces 
We could 
identify 
Pikromycin 
Medium 
Gym 4 
extracted 
with 
ethylenacetat 
and  
resuspended 
in methanol  
Opok_MB_A6 OPOK_Pj1_7_R2A Streptomyces 
narbonensis 99 % 
Streptomyces 
phaeochromogen
es 99 % 
Streptomyces 
venezuelae 99 %  
 Bacteria; 
Actinobacteria; 
Streptomycetales; 
Streptomycetacea
e; 
            
Streptomyces 
Sometimes 
inhibition 
of E. coli 
and S. 
aureus 
concentrated 
Medium 
Gym4  
Opok_MB_B11 OPOK_Pj1_48c_R2A Streptomyces 
violascens 100 % 
 Streptomyces sp. 
100 %  
 Bacteria; 
Actinobacteria; 
Streptomycetales; 
Streptomycetacea
e; 
            
Streptomyces 
We could 
identify 
Actinomyci
n D or C2 
Medium 
Gym 4 
extracted 
with 
ethylenacetat 
and  
resuspended 
in methanol  
Opok_MB_C10 OPOK_Pj1_70_NA Streptomyces 
lateritius 100 %   
Streptomyces 
phaeochromogen
es 99 %  
Streptomyces sp. 
99 %  
 Bacteria; 
Actinobacteria; 
Streptomycetales; 
Streptomycetacea
e; 
            
Streptomyces 
We could 
identify 
Pikromycin 
Medium 
Gym 4 
extracted 
with 
ethylenacetat 
and  
resuspended 
in methanol  
  
Rustemi E. Antimicrobial potential of actinobacterial inhibitors of Mur ligases in bacterium C. difficile.  
   M.Sc. Thesis (Du2). Ljubljana, Univ. of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
 
 
 
ANNEX L 
Flowchart of the experimental work using native C. difficile DNA 
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ANNEX M 
Flowchart of the experimental work using synthetic C. difficile DNA 
 
